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Abstract 
Heme oxygenase-1 (HO-1) is well known for being involved in antioxidant defence. 
BTB and CNC homology1 protein (Bach1) is involved in the transcriptional regulation 
of the HO-1 gene as a negative regulator. In human skin cells, HO-1 induction 
protects against UVA-induced cellular damage. Previous studies from this laboratory 
have found that during this process, suppressing the Bach1 level regulates HO-1 
expression level. However little is known about whether repression of Bach1 would 
enhance HO-1 protection against UVA damage. In this study, we silenced Bach1 by 
specific siBach1 RNA and showed that Bach1 repression does not protect against 
UVA induced damage in cultured human skin fibroblasts. However, silencing of Bach1 
in skin fibroblasts was shown to be involved in the process of UVA-induced ROS 
generation. We observed that UVA-induced ROS generation is independent of HO-1 
induction. This led us to investigate further the mechanism by which UVA-induces 
ROS in cultured human skin cells; we targeted NADPH oxidase (NOX) as the major 
source of UVA-induced ROS generation in human skin cells, and showed that 
following UVA irradiation, NOX is activated to different extents in two cultured human 
skin cell lines (i.e. FEK4 cells and HaCaT cells). The possible involvement of different 
NOX proteins was then studied and the results showed that NOX1 and NOX4 both 
contribute to the NOX activation process but to different extents. NOX1 and NOX4 
protein expression levels were also induced to different extents following UVA 
irradiation of FEK4 cells and HaCaT cells. The NOX general inhibitor, diphenylene 
iodonium (DPI), was used in this study to repress NOX, and we showed that this 
general inhibitor of the enzyme reduced ROS generation following UVA irradiation in 
human fibroblasts. This data is consistent with a previous study showing DPI inhibition 
of UVA-induced ROS generation in keratinocytes. However, using specific siRNA 
knock-down reagents, NOX1 and NOX4 were found to have only a limited contribution 
to the UVA-induced ROS generation process in human skin fibroblasts, a result 
consistent with the involvement of additional NOX proteins in this pathway. 
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Chapter 1 Introduction 
1.1 Human skin 
1.1.1 Human skin structure  
Skin is responsible for various functions in the human body, such as 
absorption, secretion, protection by virtue of the barrier and sensitivity of 
thermal balance. Human skin is the most widely distributed organ and 
occupies the largest area of any one component of the human body. Since it 
is the first line of defence against the external environments of the human body, 
skin plays a crucial role in defending against various external toxic chemicals 
or physical factors which can induce damage and also acts as an important 
internal barrier in preventing water loss and maintaining temperature. Unlike 
the smooth surface perceived at a distance from the surface of the skin, the 
skin tissue is covered by grooves. The skin includes three major layers: 
epidermal layer, dermal layer, and subcutaneous tissue (Celleno and Tamburi, 
2009).  
1.1.2 Epidermal layer  
The epidermal layer is the outer layer of the skin which separates the external 
environment from the skin. Its thickness varies from 0.5 mm of the thinnest 
area to 1.5 mm of the thickest area (Celleno et al., 2009). The epidermal layer 
is mainly keratinocyte cells which include: stratum basale, stratum granulosum 
and the outer layer, stratum corneum. 
The function of keratinocytes is primarily to make the protein keratin; it is 
responsible for epidermal layer turnover since keratinocytes grow and die 
towards the external surface of the epidermal layer to keep the continual 
renewal of epidermis. Melanocytes are also an important component in the 
epidermal layer, in charge of producing melanin. Langerhans cells are situated 
just above the basal layer of the epidermis, and are involved in immune 
surveillance system (Celleno and Tamburi, 2009). Certain organs of the 
Page | 14  
human body contain Merkel cells such as finger tips and lips (Celleno and 
Tamburi, 2009).  
Immediately under the epidermal layer is the basal membrane (epidermal-
dermal junction) which makes up a complex structure to connect the epidermal 
crests and dermal papillae. 
1.1.3 Dermis layer 
Under the epidermal layer is the dermal layer of the skin. The dermal layer is 
much thicker than the epidermal layer (Evans et al., 2013). Dermal 
dendrocytes, mast cells and fibroblasts are the major cell types in dermal layer 
(Kanitakis, 2002). Fibroblasts synthesise fibres and they are the major cell type 
of the dermis, which includes two morphologically different sub layers known 
as the papillary and reticular dermis (Celleno et al., 2009). The reticular dermis 
contains collagen fibres and supports dermis structures to support the 
mechanical strength such as: collagen I and elastin (Evans et al., 2013). 
Furthermore, macrophages and lymphocytes are distributed all over the 
dermis. 
1.1.4 Hypodermal layer 
In the deepest layer of skin, is the hypodermal layer. The main cell type of this 
layer is the adipocyte. The hypodermal layer contains fat and is important in 
the storage of energy and the regulation of temperature (Kanitakis, 2002). 
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1.2 UVA 
1.2.1 History of ultraviolet radiation 
The word ultraviolet (UV), meaning "beyond violet", originated from the Latin 
word ultra, meaning beyond, and violet is the colour of the shortest 
wavelengths of visible light. The wavelengths of ultraviolet (UV) light are 
shorter than visible light but longer than X-rays. The discovery of solar UV 
radiation was a gradual process which spanned three centuries (Hockberger, 
2002). Salsa made an observation in 1614 that sunlight turns silver nitrate 
crystals black. In 1801, Ritter noticed that the invisible rays beyond the violet 
end of the spectrum were more effective on dark silver chloride soaked paper, 
thus he named them deoxidising rays. The terms ultraviolet and infrared 
radiation were eventually used (Hockberger, 2002). After this, the term 
chemical rays was adopted and became popular throughout the 19th century. 
Many studies on chemical rays and their ability to stimulate chemical reactions 
were undertaken. In 1865, Maxwell proposed the theory that the light and 
sound are part of larger spectrum of energy with wave-like properties 
(Hockberger, 2002). Also, he named them electromagnetic waves. In the 
early 20th century, some new discoveries in photochemistry and photophysics 
helped the understanding of the theoretical behaviour of electromagnetic 
radiation. 
In 1900, Planck proposed that electromagnetic radiation is comprised of 
packets of energy which were definite "quanta, and then, Bohr discovered 
that electrons absorb light energy and also re-emit it at the wavelengths 
corresponding to the electrons energy. Schrödinger suggested a theory of 
wave mechanics that treated electrons as waves rather than particles.  
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1.2.2 Main types of UV radiation 
The electromagnetic spectrum of ultraviolet light can be subdivided in a 
number of ways. The draft ISO standard on determining solar irradiances 
(ISO-DIS-21348) describes the following ranges (Table 1): 
Table 1 UV radiation types 
Name Abbreviation Wavelength (nm) 
Extreme EUV 10-121 
Vacuum VUV  10-200 
Far FUV 122-200 
Ultraviolet C UVC 100-280 
Middle MUV 200-300 
Ultraviolet B UVB 280-315 
Near NUV 300-400 
Ultraviolet A UVA 315-400 
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Biologist use the term UVC to describe the ultraviolet radiation with 
wavelengths below 280 nm and this radiation is absorbed by the ozone layer. 
UVA (solar region between 315 and 400 nm) penetrates window glass and 
causes physiological effects on organisms. The UVB region of the solar 
spectrum is between that of UVC and UVA, and is believed to be the major 
region responsible for the deleterious effects of sunlight on living organisms. 
The ozone layer of the Earth blocks most solar UV radiation in the UVB and 
UVC region because they are strongly absorbed by the ozone layer and other 
molecules in the atmosphere. As a result, UVA contributes most of the 
ultraviolet radiation that reaches the surface of the earth. 
1.2.3 Harmful effects of UVR 
In humans, skin is the main organ exposed to UV radiation and long term 
exposure to solar UV radiation (UVR) may cause harmful effects on the human 
body. A report in 1928 by Findlay described that skin tumours developed in 
depilated albino mice exposed to UV rays for 8 months from a quartz Hg 
vapour lamp (Hockberger 2002). Tyrrell (1995) confirmed that UVA may cause 
more levels of cellular damage in human skin tissue than UVB radiation (Tyrrell, 
1995). UVA penetrates deeply into human skin and, like UVB, it can cause 
sunburn. UVA generates highly reactive chemical intermediates such as 
hydroxyl and oxygen radicals, which in turn can cause damage indirectly.
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1.3 Reactive oxygen species (ROS) 
With two unpaired electrons the ground state of oxygen is the most stable. 
Oxygen can act as an oxidant, and singlet oxygen is a more reactive state that 
can be achieved by insertion of energy above the ground state of oxygen; 
singlet oxygen is a non-radical since it has both paired electrons (Fukuto et al., 
2012). However, when a single electron is added to ground state oxygen, a 
superoxide radical (O2
.-) forms (Scheme 1). A peroxide anion (O2
2-) forms when 
an additional electron is added to a superoxide radical; in the presence of two 
protons, hydrogen peroxide (H2O2) is then formed, when two electrons and 
two protons are added to hydrogen peroxide, the product is water (H2O) 
(Fukuto et al., 2012; Miller et al., 1990). 
O2
1e-         O2._ 1e-          O22- 2H+      H2O2 2e-, 2H+         2H2O 
Scheme 1. The major pathway of reactive oxygen species formation. 
Reactive oxygen species (ROS) refer to a group of oxygen derived small 
molecules, which include radicals: peroxyl (RO2
. ), alkoxyl (RO-); and also non-
radicals that can be easily converted to radical molecules such as: 
hypochlorous acid (HOCl), ozone (O3), singlet oxygen (1O2), and hydrogen 
peroxide (H2O2) (Guerin et al., 2001; Kodama, 1988).  
Many findings revealed that ROS are involved in the host defence, and 
additional research on ROS indicated that they are widely involved in the 
regulation of many reversible physiological processes (Nose, 2000; Pourova 
et al., 2010). In normal aerobic systems, ROS are short-term and continuously 
generated small molecules. However, once excessive ROS have been 
generated, they interact with cellular lipids, membranes, proteins and nucleic 
acids to damage or alter the function of these molecules. Thus, ROS have 
been considered as a major source of damage in various biological organisms 
(Kohen, 1999). During these processes, O2
._  reacts with a single proton to 
produce HO2
.  , Which is more reactive than O2
._. It can initiate lipid peroxidation, 
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with most of O2
._ coming from the membrane bound system, thus either O2
._  or 
HO2
.  could cause damage to cells since O2
._  is highly reactive (Harman, 1956). 
O2
._  can also reduce antioxidant enzyme activity, examples of which are 
catalase, ribonucleotide reductase and glutathione peroxidase (Harman, 
1956). As a superoxide derived species, peroxynitrite is mostly produced by a 
fast reaction between O2
._  and NO.. 
1.3.1 Cytotoxicity of ROS 
Excessive ROS can induce cytotoxicity including both apoptosis and necrosis 
(Matsuzawa and Ichijo, 2008). ROS are considered to be involved in 
programed cell death by activating a number of signalling pathways (Jacobson, 
1996). For example, apoptosis signal-regulated kinase 1 (ASK1) can be 
activated in stress conditions by generating ROS (Tobiume et al., 2001). 
Studies have shown that ROS play an important role in the process of TNF- 
induced cytotoxicity in murine fibrosarcoma cells (Goossens et al., 1995). In a 
neuron-degeneration system, Mitochondriaderived ROS can induce 
oxidative stress which then leads to the cytochrome C release, caspase3 
activation and then finally results in apoptotic cell death (Honig and Rosenberg, 
2000). Oxidative stress induced by high glucose leads to activation of various 
signal pathways that lead to apoptosis in vitro: P38, mitogen-activated protein 
kinase (MAPK) was activated in podocytes; Bax (Bcl-2 associated X) protein 
was increased in renal epithelial cells (Wagener et al., 2009). 
1.3.2 Oxidative stress  
As described above the term oxidative/nitrosative stress refers to a serious 
imbalance of ROS/Reactive nitrogen species (RNS) production and 
antioxidants (Harman, 1956). ROS induced oxidative stress can provide 
various type of cellular and molecular damage (DNA modification, lipid 
peroxidation, protein damage and induction of inflammatory cytokines) which 
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are involved in human skin diseases including cancer (Briganti and Picardo, 
2003). Oxidative stress may result from diminished antioxidant levels or 
increased production of ROS/RNS (Harman, 1956). Oxidative stress can be 
induced by both free radicals (superoxide anion radicals, nitric oxide radicals, 
hydroxyl radicals and trichloromethyl radicals) non-radical oxidants (hydrogen 
peroxide, peroxynitrite and disulphides) and non-radical thiol-reactive 
chemicals (Jones, 2008).  
Although there was some debate about the term free radicals, the simple 
definition of free radicals refers to a species that has one or more unpaired 
electrons which are able to exist independently (Halliwell and Gutteridge, 
1999). The unpaired electron could become highly reactive. Radicals can form 
in several ways: either when a paired electron loses one electron or adding a 
single electron to a non-radical. Additionally, radicals form when homolytic or 
heterolyic fission occurs between covalent bonds (von Sonntag, 1987). 
Harman (1956) developed the first landmark theory claiming that free radicals 
contribute to the aging process. 
Figure 1 Several pathways of radical formation.
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As free radicals are small and diffusible and have an unpaired electron, they 
have been considered as a major factor in damaging macromolecules. In 
biological systems, oxidative stress induced damage is more related to the 
free radical initiation procedure since free radical scavenging by antioxidant 
enzymes and chemicals (such as vitamins E&C) can completely prevent the 
free radical chain reaction when the antioxidant concentration is high enough 
(Jones, 2008). 
1.3.2 Consequences of oxidative stress 
In normal physiological environments, cells often incur a mild oxidative stress. 
To maintain the balance of oxidants and antioxidants, the mild oxidative stress 
can induce a cellular protective response such as control of gene expression 
to increase antioxidant defence (Godic et al., 2014). However, when the 
antioxidant cannot maintain the balance of the oxidants, cellular injury may 
occur.  
Intracellular antioxidant enzymes are involved in prevention of oxidative stress 
and protect against ROS-induced potential cellular damage. These enzymes 
include glutathione peroxidase, catalase and superoxide dismutase. 
Glutathione peroxidase reduces hydrogen peroxide to water. Superoxide 
dismutase reduces super oxide anions to hydrogen peroxide. When the 
oxidant production is more than the antioxidants potential present, imbalance 
occurs. Oxidative stress is therefore also defined as excess levels of oxidants 
over antioxidants within a physiological system (Thannickal and Fanburg, 
2000). The important consequence of oxidative stress is that the redox state 
changes to a more oxidising status for components of biological systems 
(membrane, nucleus and mitochondria) (Drummond et al., 2011). 
Overall, oxidative stress can result in either adaptation or cellular damage. In 
cells, oxidative stress causes various types of damage to biomolecules 
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including lipids, proteins and DNA (Godic et al., 2014; Kehrer, 1993; 
Narendhirakannan and Hannah, 2013a). The sequence of injury differs 
depending on the type of oxidising agent. For example, double-stranded DNA 
breaks occur before detectable lipid peroxidation or protein damage in H2O2
damaged mammalian cells (Schraufstatter et al., 1986). Enzymes and 
receptors as well as transporter proteins are important targets in the early 
stages of oxidative stress damage to cells.  
Since ROS are capable of modifying DNA chemically, they are therefore 
carcinogenic (Han and Chen, 2013). When exposed to molecular oxygen, 
especially in the presence of metal ions, a series of free radical oxidation chain 
reactions arises and will damage the cell membrane component of 
polyunsaturated fatty acids. This is also known as lipid peroxidation (Harman, 
1956). Lipid peroxidation was originally defined as the oxidative deterioration 
of polyunsaturated lipids (composed of polyunsaturated fatty acids made up 
of two or more carbon-carbon double bonds) (Nowak, 2013). Lipid 
peroxidation begins with any species which can abstract a hydrogen atom from 
the methylene (CH2) group. Hydroxyl radicals are able to attack lipids to 
directly initiate lipid peroxidation, OH. also interacts with surface proteins such 
as glycoproteins (Niki, 2009; Yin et al., 2011). When the lipid peroxidase is 
activated, carbon radicals form and then react with O2 to initiate a chain 
reaction (Niki, 2014). It has been proven that proteins generate carbonyls and 
peroxides on the peptide backbone when under irradiation and that the 
selective amino acid side residue chains, amino acid peroxides became 
unstable as a result of heating or when transition metal ions are added (Denu 
and Tanner, 1998). 
Oxidative stress may cause various cellular damage pathways for example, 
cell death, and ion status disruption as well as DNA damage. Severe oxidative 
stress in cells may cause suicide responses due to a failure of adenosine 
triphosphate (ATP) production as a result of depletion of cellular nicotinamide 
adenine dinucleotide/nicotinamide adenine dinucleotide phosphate 
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(NAD+/NADP+) level by excessive poly (ADP-ribose) polymerase (PARP) 
activation (Schraufstatter et al., 1986). Necrosis and apoptosis also occur 
under severe oxidative stress. Necrotic cells can release iron and copper ions, 
superoxide releases iron from ferritin proteins; peroxide also releases iron by 
heme protein degradation; peroxynitrite can interact with iron-sulphur proteins 
and then release iron (Narendhirakannan and Hannah, 2013b; Tandara and 
Salamunic, 2012). 
Oxidative stress can cause an increase in free intracellular Ca2+ levels and 
then activate certain signal transduction pathways (Booth et al., 2011). The 
consequence of this is membrane blebbing which arises from cytoskeleton 
disruption. Apart from deregulation of Ca2+ levels, oxidative stress also 
interferes with iron in cells (Aroun et al., 2012). 
ROS lead to DNA damage by direct chemical attack and by indirect pathways, OH. interacts with DNA to generate various products through attacking sugars, 
purines and pyrimidines (Breen and Murphy, 1995). 
1.3.3 Origin of ROS in cells  
ROS are mainly generated by cellular metabolism pathways such as NADPH 
oxidase, xanthine oxidase and oxidative phosphorylation or external stimuli 
which includes UVA radiation (Brieger et al., 2012; Guerin et al., 2001).   
There are two major types of intracellular sources of ROS by metabolism 
pathways: enzymatic and non-enzymatic sources. The smooth endoplasmic 
reticulum (ER) contains enzymes which catalyse harmful metabolic products 
from lipid or membrane soluble drugs. For example, cytochromes P-450 
oxidises unsaturated fatty acid and reduces molecular oxygen to superoxide 
anion or hydrogen peroxide (Thannickal and Fanburg, 2000). Peroxisomes are 
considered to be a major source of total cellular hydrogen peroxide production 
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(Boveris et al., 1972). Intracellular soluble enzymes also generate ROS 
through the catalytic cycling procedure. These enzymes include: xanthine 
oxidase, aldehyde oxidase, flavoprotein dehydrogenase (McKelvey et al., 
1988). Peroxidase, nitric oxide synthase and tryptophan dioxygenase can also 
generate superoxide radicals (Harman, 1956). During the respiration process, 
NADPH oxidase can produce ROS (Brieger et al., 2012). The non-enzymatic 
source include the single electron transfer from flavins or iron clusters (Turrens, 
2003). 
1.3.4 UVA induced ROS in skin 
As an oxidative stress inducing agent, UVA radiation is a major factor in 
generating excessive ROS in human skin to cause an imbalance between 
antioxidants and oxidants. This will potentially lead to pathological results in 
the skin (Bickers and Athar, 2006). 
As one of the most important organs in human body, the human skin serves 
as a biological barrier that protect against external insults. Skin is the most 
widely and frequently exposed organ to environmental agents such as 
physical and chemical pollutants and is therefore much easier to damage than 
other human body components. These agents include: oxygen, chemicals 
applied in daily life, UV light, bacteria and excretion of sweat (Gutteridge et al., 
1985a; Narendhirakannan and Hannah, 2013a).  Transition metal ions (such 
as iron and copper) in sweat are potentially involved in free radical reactions. 
The cytotoxic products of these reactions can also aid the growth of bacteria 
(Gutteridge et al., 1985b). 
The major insult that skin normally faces is UV light. Despite the beneficial 
effect that UV light can have such as Vitamin D synthesis, hormone and mood 
regulation (Polefka et al., 2012), too much exposure to UVR causes either 
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acute or chronic; direct or indirect damage to skin cells (Matsumura and 
Ananthaswamy, 2004). For direct exposure, cellular molecules which absorb 
UV light may undergo structural modifications, with resultant functional 
damage including to the DNA. This can occur by disruption of DNA repair or 
replication or a gene mutation (p53) which may lead to cell cycle dys-function 
and apoptosis (Trouba et al., 2002). Indirect exposure happens when 
photosensitisers (porphyrins, flavins) in the skin absorb a photon from UV 
radiation and are excited to a higher energy state; the excited photosensitisers 
are then capable of undergoing electron transfer reactions to form reactive 
oxygen species. This leads to cellular oxidative stress and damage (Wondrak 
et al., 2006).  
With reference to acute damage, exposure to UVR causes skin roughness, 
skin redness (Masaki, 2010) and oedema (Kevin J. Trouba). Since the skin is 
constantly exposed to the oxidative stress caused by UVR, oxidised skin 
lipids/membranes and protein could lead to various skin pathologies. UVA 
radiation can cause cellular DNA damage by indirect mechanisms which 
involves cellular chromophores which can act as endogenous photosensitisers 
(Kielbassa et al., 1997; Tyrrell, 1990). Various oxidative DNA modifications 
such as strand breaks, sites of base loss and DNA-protein cross links are also 
generated by UVA (Kielbassa et al., 1997).  
In human skin, the chronic exposure of UV leads to photo ageing and 
carcinogenesis (Tyrrell and Reeve, 2006). Long-term exposure to sunlight is 
the main risk in development of human skin cancers including basal or 
squamous cell carcinomas and melanoma. UVA penetrates deeply into the 
dermis, and acts as an oxidising carcinogen in mice (Tyrrell and Reeve, 2006). 
These pathological events are both cumulative with UV dose and wavelength 
dependent. Work from this laboratory has shown that labile iron (Pourzand et 
al., 1999) and free heme (Kvam et al., 1999b) are released as a result of UVA 
irradiation of cells. UVA radiation can generate various active oxygen 
intermediates. It produces peroxides, hydroxyl radicals, superoxide anions 
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and singlet oxygen from cellular chromophores; the major biological effects of 
UVA radiation depend on oxygen and can be modified by antioxidants (Tyrrell 
and Reeve, 2006).  
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1.4 NADPH oxidase (NOX) 
1.4.1 NADPH oxidase family 
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase refers to a 
trans-membrane protein family which transfers electrons and was first 
discovered in phagocytes. A gene coding the subunit of phagocyte NADPH 
oxidase (NOX) was found in the 1980s; namely, gp91phox, and is also known 
as NOX2. A wide range of NADPH oxidases were later found in other cell types 
such as fibroblasts, tumour cells and vascular smooth muscle cells (Griendling 
et al., 1994; Meier et al., 1991). Rossi and Zatti (1964) first proposed that 
NADPH oxidase was responsible for the respiratory burst. NADPH oxidase 
transfers electrons across biological membranes via flavin adenine 
dinucleotide (FAD) to oxygen (Figure 2). The two heme groups in NOX 
function as an electron donor to reduce oxygen to superoxide (Paletta-Silva et 
al., 2013). 
The NADPH oxidase family includes seven isoforms: NOX1, NOX2, NOX3, 
NOX4, NOX5, Dual oxidase 1 (DUOX1) and DUOX2. Furthermore, six more 
subunits have been recognised, which include p47phox and NOXO1 as two 
organizer subunits; p67phox and NOXA1 as two activator subunits and 
DUOXA1 and DUOXA2 as DUOX-specific maturation factors (Bedard and 
Krause, 2007). NOX family activation requires several additional subunits and 
regulatory proteins: p22phox; NOXO1 (organiser subunits), p47phox; p67phox and 
NOXA1 (activator subunits); p40phox; Rac GTPsae. 
All of the NOX isoforms have the common structure of six trans-membrane 
domains (Figure 2). The central trans-membrane domains contain two 
histidine residues and the heme-binding region. Both a conserved FAD 
binding site and a NADPH binding site are located in the cytoplasmic COOH 
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terminus. It was proposed that NOX transfers electrons firstly from NADPH to 
FAD, then to heme and finally to oxygen (Bedard and Krause, 2007). 
Figure 2 NADPH oxidase structure. 
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1.4.2 The NOX family in physiological and pathological process 
The NOX family are believed to be essential in normal physiological process, 
such as, cell growth and apoptosis (Brown and Griendling, 2009). Different 
isoforms of the NOX family play different roles and dysfunction of the isoforms 
may induce various pathologies (Table 2).  
NOX1 
NOX1 was first purified from colon epithelial cells (Paletta-Silva et al., 2013). 
Later, NOX1 expression was found in various tissues and cell lines including 
retinal pericytes, prostate, endothelial cells and vascular smooth cells (Bánfi 
et al., 2000; Bedard and Krause, 2007; Suh et al., 1999). NOX1 performs 
varying physiological roles in different organs of the body including the 
cardiovascular system, the nervous system, the lung and the colon 
(Katsuyama et al., 2012). NOX1 derived ROS may plays an important role in 
the initiation of inflammatory bowel disease (Paletta-Silva et al., 2013). The 
overexpression of NOX1 in nude mouse generates ROS for tumorigenic and 
angiogenic functions indicating that dys-function of NOX1 in the colon may 
induce carcinogenesis (Rokutan et al., 2006; Suh et al., 1999).  
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NOX2 
NOX2 was the first member of the NOX family to be identified in phagocytes, 
with a wider distribution found later in tissues such as colon, ovary, prostate, 
placenta and small intestine (Cheng et al., 2001). NOX2 is believed to be 
involved in the host defence system in microorganisms (Rada et al., 2008) and 
in hypertension (Paletta-Silva et al., 2013). Absence of NOX2 or its subunit 
causes chronic granulomatous disease (CGD) (Brown and Griendling, 2009). 
NOX3 
NOX3 was found to play a critical role in organ development (Paletta-Silva et 
al., 2013). NOX3 activation requires p22phox subunit, p47phox or NOXO1, 
p67phox or NOXA1 and Rac1 (Banfi et al., 2004a; Nakano et al., 2007; Ueyama 
et al., 2006). NOX3 is strongly expressed in the inner ear, skull bone and brain 
(Banfi et al., 2004a). Foetal spleen (Kikuchi et al., 2000) and kidney (Bedard 
and Krause, 2007) also express NOX3. 
NOX4 
High levels of NOX4 have been found in kidney (Geiszt et al., 2000) and the 
enzyme is also expressed in skin cells including fibroblasts (Dhaunsi et al., 
2004), keratinocytes (Chamulitrat et al., 2004), and melanoma cells (Brar et 
al., 2002) as well as endothelial cells (Hu et al., 2005), osteoclasts (Yang et 
al., 2001), smooth muscle cells (Ellmark et al., 2005), hematopoietic stem cells 
(Piccoli et al., 2005) and neurons (Vallet et al., 2005). NOX4 activation does 
not require the cytosolic subunit for activity, but it does requires p22phox (Martyn 
et al., 2006). Some studies show that NOX4 might be constitutively activated, 
although this proposal is debated (Bedard and Krause, 2007). NOX4 is 
induced by various factors such as shear stress, hypoxia, ischemia and 
reticulum stress (Bedard and Krause, 2007). 
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NOX5 
NOX5 was characterised by two groups in 2001 (Banfi et al., 2001; Cheng et 
al., 2001). NOX5 differs from other NOX isoforms by containing a Ca2+ binding 
site on the intracellular NH2 terminal and also an EF-hand domain (Banfi et al., 
2004b). Importantly, NOX5 doesnt need an activation subunit as it is a calcium 
related homologue (Geiszt et al., 2000; Katsuyama et al., 2012). NOX5 is not 
glycosylated and can only catalyse reactions with NADPH and not NADH. The 
activation of NOX5 does not require any organiser or regulatory subunits. 
Instead, NOX5 activation is regulated by the cytoplasmic Ca2+ concentration 
(Banfi et al., 2001; Banfi et al., 2004b). 
DUOXs 
The DUOXs (DUOX1 and DUOX2) were first found in the thyroid gland (Dupuy 
et al., 1999), and function as part of the Golgi apparatus processing procedure 
(Morand et al., 2004). DUOX enzymes also contain a membrane spanning 
region and a peroxidase-like domain (Katsuyama et al., 2012). 
Although DUOXs function as a peroxidase has not yet been fully 
characterised, a recent study suggests the DUOXs primary product is 
superoxide (Ameziane-El-Hassani et al., 2005). DUOX1 can be induced by IL-
13 and IL-4 while DUOX2 can be induced by interferon- (Harper et al., 2005). 
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Location      
Other distribution                     Related Dys-function   
NOX1                              Colon Endothelium, uterus, 
prostate, osteoclasts, 
retina, placenta, 
smooth muscle.  
Hypertension, inflammation, 
lung injury. 
NOX2  Phagocytes Lymphocytes, neurons, 
endothelium, smooth 
muscle, neurons, 





















DUOX1 Thyroid Testis, airway epithelia Host defence 




Modified from Bedard and Krause (2007)  
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1.4.3 Regulator proteins of NOX 
a. p22phox
The 22 kDa membrane protein, p22phox is not glycosylated and it dimerises 
with NOX2 in a 1:1 ratio (Parkos et al., 1987). The structure contains two 
transmembrane domains with both the NH2 terminus and the COOH terminus 
in the cytoplasm (Burritt et al., 1998). p22phox was shown to translocate 
coupling of NOX1 (Laude et al., 2005), NOX2 (DeLeo et al., 2000), NOX3 
(Kawahara et al., 2005) and NOX4 (Ambasta et al., 2004) for activation, thus 
the major function of p22phox is to stabilise NOX proteins and organizer proteins. 
b. Organiser subunits 
NOXO1 and p47phox (namely, NOXO2) both have phox domains through which 
they can cooperate with phospholipids. They also both have an SH-3 domain 
for interacting with p22phox through the proline rich COOH terminus (Leto et al., 
1994). These two organiser proteins are responsible for combining with the 
activator proteins to activate NOX1 or NOX2. 
c. Activator subunits 
NOXA1 and p67phox (namely NOXA2) are both unglycosylated, cytoplasmic 
proteins containing a SH-3 domain on the COOH terminus which interact with 
the proline repeats on NOXO1 and NOXO2 and tetratricopeptide repeats at 
the NH2 terminus that interact with Rac. The structure of NOXA1 differs from 
NOXA2 by lacking a central SH-3 domain and the PB1 domain. This means it 
cannot interact with p40phox. NOXA1 can combine with NOX1, NOX2 and 
NOX3 via the activating domain (Takeya et al., 2003). 
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d. p40phox 
The p40phox protein contains a SH-3 domain, a PX domain and a PB1 domain.  
It is only stable when bound to NOXO1, and is important in NOX2 regulation; 
however it is not necessary for NOX2 activity (Bedard and Krause, 2007). 
e. Rac GTPase 
There are three Rac GTPase homologous, Rac1, Rac2, and Rac3 domains. 
Rac GTPase engages in NOX2 regulation of phagocytes (Bedard and Krause, 
2007). The Rac protein is also involved in NOX1 activation (Miyano et al., 
2006), but it is still debated whether they are involved in NOX3 or NOX4 
regulation. 
In summary, the NOX proteins require various coupling subunits for activation 
(e.g. NOX1: Rac, p22phox, NOXO1/p47phox NOXA1/p67phox; NOX2: Rac, 
p22phox, p40phox, p47phox, p67phox; NOX3: Rac, p22phox, NOXA1/p67phox, 
NOXO1/p47phox; NOX4: p22phox; DUOX1: DUOXA1; DUOX2: DUOXA2). 
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1.4.4 NADPH oxidase and ROS 
NOX has been considered a major source of ROS generation. NOX derived 
ROS include superoxide and hydrogen peroxide. NOX derived ROS can have 
a big impact on major cellular process as they can regulate signalling 
pathways. Neutrophil NOX generates a large amount of superoxide anion as 
part of the oxidative burst system. Physiological and pathophysiological 
functions that could be influenced by NOX derived ROS include host defence 
and inflammation, cell signalling, apoptosis, cell proliferation, oxygen sensing 
protein cross-linking, angiogenesis, ECM regulation and cytokine gene 
expression (Bedard and Krause, 2007).  
There is evidence that NOX is a major source of oxidative stress in ischemic 
injury of the cardiovasculature (Kleikers et al., 2012). The first recognition of 
NOX2 as responsible for ROS generation was in phagocytes (Royer-Pokora 
et al., 1986; Teahan et al., 1987). Later on, the other NOX proteins were 
gradually found to be involved in ROS generating events. 
In cells from patients with impaired ROS generation, it was found to be a result 
of NOX4 reduction (Park et al., 2005). Quantitative real-time PCR results in 
human dermal fibroblasts revealed that 3-deoxyglucosone (3-DG) collagen 
induced ROS generation is dependent on NOX4 overexpression and 
fibroblasts pre-treated with the NOX general inhibitor apocynin also had 
reduced ROS generation (Loughlin and Artlett, 2010). In hairless mouse skin, 
UVB induced NOX4 expression (Rahman et al., 2011). Silencing the NOX4 
gene augments melanin formation and largely decreased the basal and alpha 
melanocyte stimulating hormone (-MSH) induced ROS generation in B16 
melanoma cells (Liu et al., 2012). In HaCaT cells, gene knock-down of either 
NOX1 or NOX4 decreased production of ROS during early stages of wound 
healing. This indicated that NOX1 and NOX4 are involved in the NOX derived 
ROS production in HaCaT cells (Nam et al., 2010). Conversely, in vascular 
cells, NOX4 is considered to have a protective role (Schroder et al., 2012). 
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Silencing of NOX4 in human dermal fibroblasts abolished dehydroascorbic 
acid (DHA)-induced ROS generation (Rossary et al., 2007).  
1.4.5 NADPH oxidase in skin 
It has been observed that in skin cells ROS generation can be induced by 
various agents including ultraviolet light (Beak et al., 2004) and phorbol esters 
(Steinbrenner et al., 2005). More interestingly, both were inhibited by NOX 
inhibitors and that may indicate that NOX is involved (Meier et al., 1991). In 
keratinocytes, ROS generation in response to UV light was inhibited by a NOX 
inhibitor, indicating that NOX may be involved in this event (Beak et al., 2004). 
Fibroblasts have also been shown to generate ROS via NOX by various 
factors for example: very-long-chain fatty acids, insulin, IL-1 and, platelet-
derived factors (Bedard and Krause, 2007). 
1.4.6 NADPH oxidase and HO-1 
Given that NOX contains heme as a prosthetic group, it is reasonable to 
hypothesise that there may be some links/interactions between HO-1 and 
NOX. Both in vitro and in vivo, induction of HO-1 in macrophages both 
decreases NOX activity and superoxide anion release. It is proposed that 
breakdown of heme upon HO-1 induction may be the mechanism by which 
HO-1 influences NOX activity and could explain the protective role of HO-1 
induction during oxidative stress (Taille et al., 2004). Similar results were found 
in apolipoprotein Edeficient mice (Datla et al., 2007), where HO-1 induction 
decreased NOX activity and superoxide generation. Bilirubin also decreased 
NOX generated superoxide induced by oxidative stress in human neutrophil-
like HL-60 cells (Datla et al., 2007).
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1.5 Cellular antioxidant defence  
In response to excessive ROS conditions, our body engages antioxidant 
protection defense systems (Gomes et al., 2012). The antioxidant defense 
pathways are normally through scavenging the ROS and interaction with ROS 
products (Godic et al., 2014). 
Antioxidants include two major categories, either non-inducible or inducible by 
oxidising agents (e.g. UVA). 
The non-inducible antioxidants include enzymatic and non-enzymatic. 
Enzymatic antioxidants include catalase, glutathione peroxidase, superoxide 
dismutase and thioredoxin (Cheeseman and Slater, 1993; Holmgren, 1985). 
These antioxidant molecules have strong free radical scavenging properties; 
non-enzymatic antioxidants include vitamin E, vitamin C, glutathione, uric acid, 
and ubiquinol (Pandel et al., 2013; Poljsak et al., 2013). 
Among these two major categories, the antioxidants also distinguish as 
endogenous and exogenous. Asorbic acid, vitamin E and coenzyme Q10, 
belong to exogenous antioxidants. Glutathione peroxidase, superoxide 
dismutase and catalase belong to endogenous antioxidants (Pandel et al., 
2013). 
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1.5.1 Heme oxygenase (HO) 
UVA radiation causes damage as a result of ROS, which are induced by 
oxygen-dependent photosensitisation reactions (Reeve and Tyrrell, 1999). 
UVA can also induce genes encoding antioxidant proteins (e.g. glutathione 
peroxidase, superoxide dismutase etc.) which protect against the presence of 
ROS (Reeve and Tyrrell, 1999). In 1989, Tyrrell (Tyrrell and Pidoux, 1989) 
reported that a major 32 kDa stress protein, identified as heme oxygenase, 
was induced by UVA radiation (HO; EC 1.14.99.3) (Tyrrell and Pidoux, 1989). 
UVA radiation of human skin fibroblasts can cause induction of heme 
oxygenase messenger RNA (mRNA) and protein (Keyse and Tyrrell, 1987; 
Keyse and Tyrrell, 1989). It can also release heme, from microsomal heme-
containing proteins which correlates with UVA-mediated HO-1 activation 
(Kvam et al., 1999a). 
1.5.1.1 Heme  
The term heme refers to a group of an iron chelated in a porphyrin ring; the 
porphyrin ring is known as protoporphyrin IX. The chelated iron is involved in 
the oxidation state when heme compounds are biological catalysts (Maines 
and Kappas 1977). There are three major kinds of biological heme, heme A, 
heme B and heme C. Heme B is the most common type. Hemes are commonly 
recognised as components of hemeoproteins. 
1.5.1.2 Hemeoproteins 
A hemeprotein is a metalloprotein which contains a heme group, either 
covalently or non-covalently bound to the protein itself. Hemeoproteins have 
several biological functions including diatomic gas transport, biological 
catalysis as enzymes and electron transfer.
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1.5.1.3 Heme oxygenase structure and function 
Heme oxygenase (HO) is a protein with the function of degrading heme. All 
studies have shown that HO is a distinct enzyme which can degrade heme. 
HO starts to degrade heme by binding to heme at a 1:1 ratio. It then converts 
heme to biliverdin, in this process oxygen and NADPH are required (Figure 3) 
(Tenhunen et al., 1968; Tenhunen et al., 1969). HO consists mostly of a helix 
in the folding domain. The substrate of heme is connected by the proximal 
helices and distal helices as a sandwich (Unno et al., 2007).   
When reducing agents are present, heme oxygenase degrades heme into 
biliverdin, iron and CO. Each of the products has different properties. Biliverdin 
is then reduced by its reductase to bilirubin in mammals. Although bilirubin is 
considered to be an antioxidant, excessive amounts are harmful. Iron can also 
trigger lipid peroxidation (Unno et al., 2007). CO can participate in various 
biological functions such as: regulation of neuroendocrine (Pozzoli et al., 1994) 
and vascular tone (Kaide et al., 2001) and hemeorrhagic shock (Pannen et al., 
1998). Fe2+ is a crucial metal in the Haber-Weiss reaction (Figure 4). 
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Figure 3 Mechanism of Heme oxygenase degrading heme (Modified from 
Unno et,al., 2007).
Figure 4 A diagram of the Haber-Weiss reaction. 
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1.5.1.4 Types of heme oxygenase and their functions 
There are two major types of heme oxygenase (HO) known so far, which are 
HO-1, HO-2 (Maines et al., 1986; Trakshel et al., 1986). HO-1 and HO-2 were 
first identified in the microsomal fraction of rat liver (Maines et al., 1986). 
Among the two major types of heme oxygenase HO-1 and HO-2, HO-1 is 
inducible whereas HO-2 is not. HO-1 activity can be activated by 
environmental agents such as cadmium, hypoxia, UV light and heat shock 
(Khan and Quigley, 2011). 
1.5.1.5 Mechanism of HO-1 protection  
Oxidative stress can lead to cellular pro-oxidant protection (Applegate et al., 
1991). Heme has been shown to be pro-inflammatory and produce ROS. 
Accumulation of free heme in cells can cause cell damage (Balla et al., 1991; 
Balla et al., 1993), so that removal of excess heme prevents potential cell 
damage. Since HO degrades free cellular heme to iron, CO and biliverdin, it 
serves a general function of maintaining cellular heme homeostasis. All the 
by-products of free heme degradation reaction may participate in cellular 
protection. Normally, CO is characterised as a poisonous gas, and it binds to 
hemeoglobin to deplete O2. However, a crucial role of CO has been 
characterised in cellular protective process such as anti-inflammatory and anti-
apoptotic responses (Brouard et al., 2000; Ryter et al., 2006). HO-1 has also 
been proposed to play an important role in several disease conditions which 
include: psoriasis, transplant rejection and alzheimers disease (Raval., 2008). 
UVA radiation strongly activates HO-1 in human skin fibroblasts (Keyse and 
Tyrrell, 1989). UVA therefore induces the heme-catabolising enzyme, heme 
oxygenase in mammalian skin. This enzyme is associated with a major anti-
inflammatory response in several tissues and has been shown to protect 
against several disease states (Tyrrell and Reeve, 2006).  
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1.5.1.6 UVA-mediated HO-1 gene activation 
It is important to understand the UVA-mediated regulation of HO-1 gene 
activation. Recent studies have shown that under normal physiological 
conditions, HO-1 expression is repressed by Bach1, and increased heme 
levels displace Bach1 from the promoter and allowing activators to bind to it 
(Sun et al., 2002). 
The human HO-1 gene is located on chromosome 22q12; it has five exons 
and spans up to 14 kb (Hill-Kapturczak et al., 2003; Kutty et al., 1994). In 2003, 
Hill-Kapturczak demonstrated that the human HO-1 gene promoter has two 
upstream regions, one between -4.5 and -4.0, and another one between -9.1 
and -4.5, which are required for activation of the HO-1 gene by heme (Hill-
Kapturczak, Sikorski et al. 2003). Both these enhancer regions contain 
multiple stress responsive elements (StRE) and Maf recognition elements 
(MARE).  
Under stress conditions, HO-1 is activated and, during this process, it has 
been shown that the NF-E2-related factor (Nrf2) along with the small 
musculoaponeurotic fibrosarcoma (Maf) protein form a heterodimer which can 
then bind to the MARE site of the HO-1 gene promoter (Sun et al., 2004). Nrf2 
is stabilized in the cytoplasm by Keap1 protein under normal conditions, but is 
then released in response to the various stimuli. As a repressor protein, Bach1 
competes with Nrf2 under normal conditions to form the heterodimer with Maf 
protein that binds to the MARE site on the HO-1 promoter (Figure 5A). Under 
stress condition (e.g. UVA irradiation), Bach1 binds to heme and is released 
from the MARE sites. This allows the activator protein (MafK/Nrf2) to bind to 
the same site for HO-1 gene activation (Sun et al., 2004) (Figure 5B). 
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Figure 5 HO-1 gene regulations. A: Under normal conditions, Nrf2 is bound by 
Keap1 in the cytoplasm and Bach1 combines with Maf to occupy the MARE 
site of the HO-1 gene promoter and represses the transcription. B: Following 
UVA irradiation, free heme released by UVA binds to Bach1 and releases its 
binding to the promoter. This allows Nrf2 to occupy the MARE site and activate 
HO-1 gene transcription.   
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1.5.2 Bach family  
Basic leucine zipper proteins (bZip) are responsible for interactions with 
several different families of transcription factors through forming heterodimers. 
Such heterodimer formation controls gene regulation during the process of 
cellular organism development (Oyake et al., 1996b).  
Transcriptional factor NF-E2 is one of the proteins containing the bZip subunit 
thereby providing it with DNA binding activity (Oyake et al., 1996b). NF-E2 
consists of a large and a small bZip subunit (Andrews, Erdjument-Bromage et 
al. 1993). The large subunit belongs to the Capncollar (CNC)-type bZip 
protein family, which is also named p45. The CNC family includes p45, NF-E2, 
Nrf1/LCRF1/TCF11 and Nrf2 (Caterina et al., 1994; Chan et al., 1993; Luna et 
al., 1994; Moi et al., 1994). 
It has been proven that Bach protein belongs to the BTB (Broad complex
TramtrackBric-abrac-Basic Leucine Zipper) transcription factors which can 
regulate certain genes and interact with small Maf family protein such as MafK, 
Maf F and Maf G, which are also bZip proteins (Oyake et al., 1996a) These 
complex heterodimers can therefore activate or repress gene transcription. 
The Bach family also contains a BTB domain (Oyake et al., 1996a; Zollman et 
al., 1994). Bach 1 and Bach2 were first identified as novel parts of the bZip 
family by Oyake and Itoh in 1996 (Oyake et al., 1996a). 
1.5.2.1 Bach1  
A study in Bach1 deficient mice showed high expression of HO-1 (Ochiai et 
al., 2008). Warnatz and Schmidt (Warnatz et al., 2011) recently reported that 
Bach1 interacts with genes involved in the process of oxidative stress as well 
as the cell cycle. Bach1 has also been shown to be engaged in apoptotic 
pathways and transport processes. The observation report about Bach1 
Page | 45  
binding to hyaluronan-mediated motility receptor, suggest that Bach1 is 
involved in cellular transport processes (Warnatz et al., 2011).  
The Bach1 gene plays a crucial role in induction of HO-1 expression by UVA 
radiation (Raval., 2008). Tyrrell and Keyse (1989) have shown that in human 
skin fibroblasts, UVA irradiation strongly induced HO-1 transcription and 
activation. UVA radiation induction of Bach1 protein accumulation in human 
skin fibroblasts has also been reported (Raval et al., 2012). Bach1 deficient 
mice showed depression of oxidative stress induced pancreatic -cell injury, 
and were susceptible to alloxan induced HO-1 induction (Kondo et al., 2013). 
Thus, it is reasonable to assume that a protective role of Bach1 may arise 
through HO-1 up-regulation. Zhong (2010) showed that Bach1 deficiency 
increased both basal and UVA-induced HO-1 expression in human HaCaT 
cells indicating that Bach1 is involved in UVA mediated HO-1 induction. In 
addition, silencing Bach1 reduced UVA-induced membrane damage in HaCaT 
cells (Zhong et al., 2010). 
1.5.2.2 Bach2 
Unlike Bach1, Bach2 is mainly distributed in neuronal cells and in B cells 
during differentiation (Rosbrook et al., 2012).  
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1.5.3 Glutathione  
Glutathione (GSH) is distributed in most organisms and is essential for 
maintaining cellular protein thiol status. As a tripeptide structure, GSH is 
synthesized from the amino acids L-glutamate, L-cysteine and L-glycine (Glu-
Cys-Gly) (Ehrlich et al., 2007). The function of glutathione is crucial to 
maintaining the cellular antioxidant/oxidant homeostasis as well as viability of 
cells (Fitzpatrick et al., 2012). GSH is one of the major cytosolic non-enzymatic 
antioxidants and scavenges free radicals (Ehrlich et al., 2007; Galano and 
Alvarez-Idaboy, 2011); including peroxynitrite and hydroxyl. It can also convert 
H2O2 to water. During this process, a GSH radical is formed, that would 
immediately be neutralized by binding to another GSH radical to form GSSG 
(Massaad and Klann, 2011). GSH reductase can covert GSSG back to the 
oxidized form GSH in the presence of NADPH (Fitzpatrick et al., 2012) (Figure 
6). The disruption of intracellular glutathione levels will cause dys-regulation 
of the GSH/GSSG ratio, which in turn leads to a disrupted cellular ROS 
homeostasis (Johnson et al., 2012). The decreased GSH level was observed 
in various pathologies such as: acute lung disease, Parkinsons disease 
(Ehrlich et al., 2007), this reduction was believed to cause impaired ROS 
generation which consequently leads to related pathologies due to lack of the 
protection role of GSH against the impaired ROS generation.  
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Figure 6 A diagram of the Glutathione (GSH) redox pathway. GSSG: reduced 
form of GSH, -GCS: gamma-glutamylcysteine synthase, GS: glutathione 
synthase. 
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The role of glutathione in UVA induced human skin damage has been 
examined in this laboratory, Tyrrell and Pidoux (1988) reported that 
glutathione depletion by D,L-buthionine-S,R-sulphoximine (BSO) in both skin 
fibroblasts and keratinocytes led to enhanced sensitivity to UVA irradiation. 
This suggests that glutathione functions as an antioxidant involved in 
protecting against UVA-induced human skin damage. In agreement with this, 
depletion of glutathione has been shown to increase the UVA-induced ROS 
level in HaCaT cells (Tobi et al., 2000). In contrast, if cellular glutathione levels 
are raised using NAC, ROS levels are little changed by UVA treatment (Tobi 
et al., 2000). These studies demonstrated the antioxidant role of glutathione. 
Depletion of cellular glutathione has been found to enhance the ROS level in 
UVA-irradiated cells (Tobi et al., 2000). Cellular glutathione depletion results 
in sensitization to lethal damage induced by UVA irradiation in both skin 
fibroblasts and keratinocytes (e.g. colony forming viability) (Tyrrell and Pidoux, 
1988). Another study from this laboratory has shown that the UVA induction of 
HO-1 strongly correlates with the intracellular glutathione level (Lautier et al., 
1992). There is also evidence that glutathione depletion in human 
keratinocytes (HaCaT cells) increased UVAinduced ROS generation (Tobi et 
al., 2000). 
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1.6 RNA interference  
RNA interference (RNAi) refers to the phenomenon of exogenous short RNAs 
hybridizing to endogenous messenger RNA and interfering with translation 
(Montgomery et al., 1998). This process has been used to silence specific 
genes in vivo and in vitro. Reduction of specific gene activity using double 
strand RNA was first found in caenorhabditis elegans, and later was also found 
in plants as well as mammalian cells (Montgomery et al., 1998).  
Fire and Mello first established that delivery of small double stranded RNA 
could result in more specific interference efficiency (Fire et al., 1998). Later, 
Hamilton and Baulcombe confirmed the mechanism of RNAi in mammalian 
cells (Elbashir et al., 2001). The enzyme Dicer degrades long double-stranded 
RNA (dsRNA) into small interfering RNAs (siRNA), 9~22 nucleotides (nt) in 
length (Tang, 2005), which can then be integrated into the RNA induced 
silencing complex (RISC). RISC contains a splicing protein which can cleave 
the targeted mRNA (Figure 7). 
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                   Figure 7 A diagram of the siRNA mediated RNAi pathway. 
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1.7 Aims and objectives  
The main aim of this study is to investigate the interaction between UVA 
radiation with cultured human skin cells and possible involved proteins during 
this process. We will focus on NOX and Bach1 aimed to determine the role of 
these two proteins in the process of UVA induced skin damage respectively. 
To achieve this, we will examine: 
1). The involvement of NOX in UVA induced ROS generation in cultured 
human skin cells in this process as well as the possible involved NOX subunits. 
NOX will be inhibited and UVA-induced ROS generation will be detected using 
flow cytometry. We will then detect the NOX activity upon UVA irradiation. 
Since NOX family have 7 protein members, we will also determine the possible 
involved NOX subunits. NOX1/4 protein will be mainly focused in this study 
and the expression of these two NOX proteins upon UVA irradiation will be 
detected by western blot. 
2). If repressing Bach1 would enhance the protection of the HO-1 induction by 
UVA in cultured human skin cells.  Bach1 will be repressed using RNA 
interfering technique and human skin cells cytotoxicity will be examined after 
UVA irradiation at various levels. 
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Chapter 2 Materials and methods 
2.1 Chemicals 
All chemicals were purchased from Sigma-Aldrich Chemical (Poole, UK) 
unless specified otherwise.  
Cell culture material used in this project were from Gibco (Invitrogen, UK) 
except foetal bovine serum (FBS) purchased from PAA Laboratories 
(Australia). 
2.2 Cell culture 
Human skin cell lines (FEK4 and HaCaT) used in this study were routinely 
cultured at 37°C and incubated with 5% CO2 in a humidified atmosphere. 
CuSO4 was used as an antibacterial within the incubator.  
FEK4 cells were derived from human primary foreskin fibroblasts. Passages 
9-16 were used since FEK4 fibroblasts are passage-dependent. EMEM 
(Eagle’s modified minimum essential medium) was used for culturing FEK-4 
cells. The medium was composed of 15% FBS (heat-inactivated at 56°C for 
45 min before use), 0.25% sodium bicarbonate, 2 mM L-glutamine and 50 
IU/ml each of penicillin/ streptomycin (P/S). 
HaCaT cells were derived from a human spontaneously immortalised skin 
keratinocyte. The culture medium used for HaCaT cells was DMEM (high-
glucose Dulbecco’s modified Eagles medium) containing 10% FBS and 50 
IU/ml each of penicillin/streptomycin (P/S). 
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2.3 Cell maintenance    
FEK4 cells and HaCaT cells were centrifuged at 5,000 rpm for 5 min and the 
cell pellets were suspended (i.e. by pipetting up and down) in the culture 
medium (EMEM or DMEM) containing 10% DMSO and 20% FBS. Cells 
suspensions were then aliquoted in to the sterilized cryogenic storage vials. 
Cryogenic vials containing the cells were stored at -80°C overnight and then 
transferred to liquid nitrogen for long term storage. 
When required for culture, the cells were rapidly thawed and placed in a 15 ml 
falcon tube containing 10 ml pre-warmed culture medium. After centrifugation, 
the cell pellet was then suspended in the culture medium (10 ml) and grown in 
a T75 cell culture flask. 
2.4 UVA irradiation 
A broad-spectrum 4 kW UVA lamp (Sellas, Germany) was used as a source 
of UVA radiation throughout this study. The irradiation times for corresponding 
UVA doses were calculated by measuring dose rate using a calibrated IL1700 
radiometer (International Light, Newbury, MA). 
Cells were seeded on to different dishes for irradiation experiments. On the 
day of treatment, conditioned medium was removed from each dish, cells were 
rinsed, replaced with PBS and then irradiated with UVA at required doses 
ranging from 50 to 500 kJ/m2. Irradiation was conducted in a dark room with 
air-conditioning at 18°C in order to control temperature which will increase as 
a result of the UVA source. Following UVA irradiation, cells were then either 
analysed immediately or replaced with conditioned media for further 
incubation.
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2.5 Chemical treatment 
The compounds used in this study were added to the conditioned media from 
cells which had been grown to reach a certain confluence, and treatment was 
incubated with cells for indicated times from 10 min to 48h at the required final 
concentrations depending on the experimental requirement. 
2.5.1 DPI treatment 
Diphenylene iodonium (DPI) (D2929, Sigma) stock solution was prepared in 
DMSO (dimethyl sulphoxide) at a final concentration of 10 mM and aliquots 
were stored at -20°C until use. Conditioned medium was collected and DPI 
was diluted in the conditioned medium. 
2.5.2 Plumbagin treatment 
Plumbagin (P7262, Sigma) stock solution was prepared in DMSO at a final 
concentration of 10 mM and aliquots were stored at -20°C until use. 
2.5.3 Hemin treatment 
Hemin (iron ferric protoporphyrin IX) was dissolved in DMSO at a stock 
solution of 20 µM. Hemin was added to cells and incubated for 16 h before 
treatment.
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2.6 siRNA transfection 
RNA interference was used in this study to knock down targeted genes (Bach1, 
HO-1, NOX1 and NOX4). siRNAs for silencing of Bach1/NOX1/NOX4 were 
employed. 
FEK-4 and HaCaT cells were seeded onto 3 cm plates in duplicate at a density 
of 8x104 cells per plate. Concentrated siRNA and an equal amount of 
transfection reagent (RNAi Max, Invitrogen) were both diluted separately in 
150 µl Opti-MEM, left at room temperature for 5 min, after which the siRNA 
was mixed with the transfection reagent. The mixture was incubated at room 
temperature for 30 min before being added to cells. The cells containing 
siRNAs were then incubated for 48 h. The siRNA sequences employed in this 
study are shown in Table 3. 
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Table 3 siRNA sequence used in this study. 
siRNA Sense Antisense 
NOX1A ACAAUAGCCUUGAUUCUCAUGGUAA UUACCAUGAGAAUCAAGGCUAUUGU
NOX1B GCAAUAUUGUUGGUCAUGCAGCAUU AAUGCUGCAUGACCAACAAUAUUGC
NOX4 GCCUCUACAUAUGCAAUAAtt UUAUUGCAUAUGUAGAGGCtg 
Bach1 GCCUUUGUCAGGUACAGACtt GUCUGUACCUGACAAAGGCtt
HO-1 GGCCUUCUUUCUAGAGAGGtt CCUCUCUAGAAAGAAGGCCtt
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2.7 Cytotoxicity assay 
The cytotoxicity was estimated using the cell proliferation assay (MTS assay), 
and cell membrane damage was detected by using the LDH assay. 
2.7.1 MTS assay 
MTS, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4- 
sulphophenyl)-2H-tetrazolium, inner salt, is a colourimetric assay which has 
been used widely in cell proliferations and cell viability measurement. It detects 
the ability of cellular mitochondrial dehydrogenase to convert the MTS into a 
coloured formazan product. The amount of formazan is directly proportional to 
the viable living cell number. 
The enzymatic activity was measured using the CellTiter 96® AQueous One 
Solution Assay (Promega,UK) 
For use, the MTS/SFM solution was freshly prepared by mixing MTS stock 
solution and SFM (serum free medium) (1:5) in a falcon tube to a final 
concentration of 0.5 mg/ml. After the indicated treatment, the medium was 
aspirated and the cells washed with PBS. Cells were then incubated with 100 
µl MTS solution for 1.5 h. To determine the enzyme activity, 100 µl solutions 
from each sample was transferred in duplicate to a 96 well micro-titre plate 
and the absorbance was read by VERSAmaxTM (Molecular devices, California) 
at a wavelength of 490 nm wavelength. The absorbance was expressed as a 
percentage of enzyme activity. 
2.7.2 LDH assay 
The lactate dehydrogenase (LDH) assay can indicate membrane damage, 
since LDH activity released by damaged cells can be detected. The levels of 
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extracellular LDH were determined using the cytotoxicity detection kit for LDH 
(Roche Applied Science). After 4 h and 24 h incubation, LDH activity in both 
cells and cultured medium were measured according to the manufacturer’s 
instructions. The percentage of LDH released was calculated from the values 
obtained. The release of LDH was determined by measuring the absorbance 
with a spectrophotometer plate reader at a wavelength of 490 nm. 
LDH activity: Percentage LDH release= (LDH activity released / total LDH 
activity) x 100% 
In this study, percentage LDH release was calculated using the following 
formula: Percentage LDH release = (LDH activity released in the cells / LDH 
activity in cells +LDH activity in medium) x 100%  
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2.8 ROS generation assay 
ROS generation of UVA irradiated cells were detected using 5-(and-6)-
chloromethyl-2',7'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-
H2DCFDA) in a flow cytometry assay (C6828, Molecular Probes, Invitrogen): 
stock solution was prepared in DMSO at a final concentration of 5 nM. Aliquots 
were stored at -20°C until use.   
2.8.1 Principle 
CM-H2DCFDA is a general indicator of intracellular ROS generation. On 
passive diffusion into cells, intracellular esterases will cleave the acetate 
groups. Meanwhile, intracellular glutathione and other thiols react with the 
thiol-reactive chloromethyl group. As a sequence, oxidation products generate 
fluorescence. 
2.8.2 Procedure 
FEK-4 and HaCaT cells were seeded onto 3 cm plates in duplicate for 3 nights. 
On the day of treatment, cells were incubated with DPI for 1h before UVA 
treatment as previously indicated. 5 µM CM-H2DCFDA was mixed with PBS 
and incubated with cells for 25 min. The ROS generation in the cells were then 
detected by using flow cytometry. 
For analysis of intracellular ROS generation, cells were treated with trypsin 
and re-suspended in FBS. The neutralized cells were centrifuged at 1,000 rpm 
for 5 min, washed twice using 0.1% BSA containing PBS and then centrifuged 
again (1,000 rpm, 5 min). Cells were then re-suspended in 2 µg/ml propidium 
iodide (PI).The collected cells were then transferred to a flow cytometer tube 
and analysed (10,000 or 50,000 events). The fluorescence intensity was 
quantified using a flow cytometer (Becton-Dickinson, Erembodegem, Belgium, 
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FACS CantoTM) equipped with an argon ion laser (488 nm excitation), and a 
detector at 520 nm for fluorescence emission (see appendix for ROS for 
representative ROS generation data). 
2.9 Flow cytometry (dual stain assay) apoptosis and necrosis assay 
Cell death caused by apoptosis and necrosis was measured using the Annexin 
V-FITC (AV)/propidium iodide (PI) dual staining assay to distinguish the two 
cell death pathways. The protocols were carried out as described in the 
Annexin V-FITC detection kit (Roche). 
2.9.1 Principle 
Cell surface and plasma membrane are altered in the early stages of apoptosis. 
One major change is phosphatidylserine (PS) from the inner side being 
translocated to the outer layer side, thus PS is exposed to the external surface 
of the cell. As a calcium-dependent phospholipid-binding protein, Annexin-V 
FITC (AV) has a high affinity for PS which is only exposed to the cell surface; 
this compound can be used for detecting apoptotic cells. 
When cells are exposed to extreme physiological conditions, necrosis occurs 
and the plasma membrane loses integrity and is then damaged. PI can enter 
the damaged cells by binding to the DNA; necrotic cells that lose membrane 
integrity can be stained with both PI and AV, therefore can be distinguished 
from apoptotic cells (Figure 8).
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Figure 8 Mechanism of dual staining for necrotic and apoptotic cells. Dual 
staining by Annexin-V FITC and PI was used to identify necrosis and apoptosis. 
Necrotic cells are stained with both Annexin-V FITC and PI. Apoptosis are 
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2.9.2 Procedure 
Cells were collected and washed with the incubation buffer (10 mM 
Hepes/NaOH, pH 7.4, 5 M NaCl, 100 mM CaCl2). The cells with Annexin V 
dye (20 µl/ml) were incubated at room temperature under dark conditions for 
20 min followed by 2 min incubation with PI (20 µg/ml).  
2.10 Trypan blue assay 
The cytotoxicity of diphenylene iodonium (DPI) on HaCaT and FEK-4 cells was 
tested using trypan blue dye. FEK-4 and HaCaT cells were seeded on a 6 cm 
dish with 6 ml 10% FBS containing DMEM (EMEM for FEK-4) for 3 days. 
Conditioned media was collected on the day of treatment; 2.5 ml of serial 
concentrations of DPI (0, 1, 2, 5, 10 and 20 µM) were added with conditioned 
media to the cells and incubated for 1 h. After treatment, cells were washed 
with PBS and replaced with saved conditioned media (3 ml per dish). Cells 
were incubated for 24 and 48 h and then the percentage of cell death was 
estimated counted by using trypan blue dye staining.  
2.11 Total protein extraction   
Following treatment, cells were detached with 0.25% trypsin and the pellet was 
collected by centrifugation at 13,000 rpm for 5 min. Supernatant was discarded 
and the cell pellets were suspended in 0.5 ml lysis buffer (KH2PO4, 20 mM; 
ethylene-diaminetetraacetic acid (EDTA), 0.5 mM; PMSF, 0.1%; tablet 
inhibitor) (Roche) and then transferred to a 1.5 ml eppendorf tube and, 
sonicated for 14 seconds on ice (Rapidis 300, Ultrasonics, UK). After 
sonication, cell lysate was then centrifuged at 13,000 rpm for 5 min at 4ºC 
(Biofuge 13, Heraeus instrument). The supernatant that contained total protein 
was then collected and was either used for NOX enzymatic assay immediately 
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or flash-frozen on dry ice containing 100% methanol and stored at -80ºC for 
future use. 
2.12 Quantification of protein concentration   
Quantification of protein concentrations was measured by the Bio-Rad protein 
assay according to the method of Bradford (1976). The standard curve was 
generated by using bovine serum albumin (BSA, 1 mg/ml) at a final 
concentration of 0, 1, 2, 4, 6, 10, 15, 20 mg/ml. The total protein volume or 
BSA diluted in the same solvent of protein extraction of each well was 160 µl, 
40 µl of Bio-rad protein reagent (Bio-rad, 500-0006) was then added to give a 
final volume of 200 µl. Each condition was performed in triplicate. The 
absorbance was read by VERSAmaxTM (Molecular Devices, California) with a 
595 nm filter. 
2.13 Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE)  
A separating gel was prepared using a 10% resolving polyacrylamide gel 
solution composed of 30% acrylamide/bis, 0.5 M Tris-HCl, pH=6.8, 10% SDS , 
MilliQ H2O, N,N,N',N'-tetramethylethylenediamine (TEMED) and 10% 
ammonium persulphate (APS). The gel solution was poured into an empty Bio-
Rad gel casting system and then was allowed to form at room temperature for 
1 h. MilliQ H2O was added on top of the resolving gel in order to avoid any 
evaporation. The stacking gel solution was prepared using 4% polyacrylamide 
gel composed of 30% acrylamide/bis, 1.5 M Tris-HCl, pH=8.8, 10% SDS, MiliQ 
H2O, TEMED and 10% APS. The stacking gel solution was then added on top 
of the resolving gel layer and was set for further 45 min.  
Equal amounts of protein (10 µg) were diluted in a 5x sample buffer [300 mM 
Tris, 50% glycerol, 10% sodium dodecyl sulphate (SDS), 0.5% bromophenol 
blue, 0.05% -mercaptoethanol] and then heated at 95 ºC for 5 min, and finally  
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loaded on to the SDS polyacrylamide gel. The electrophoresis was performed 
with 1x running buffer [25 mM Tris-HCl, 200 mM glycine, 0.1% w/v SDS] at 
150 Volts for 1 h.  
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2.14 Western blot analysis 
After electrophoresis, all proteins were then transferred to polyvinylidine 
difluoride (PVDF) membranes by using a tank blotting unit filled with transfer 
buffer (3% w/v tris, 14.4% w/v glycine, 20% methanol) at 14 V in a cold room 
overnight. Equal rates of transfer were confirmed by reversible staining with 
Ponceaus S. Blots were incubated with 3% BSA in Tris buffered saline with 
tween 20 (TBST) to block nonspecific binding at room temperature for 1h. The 
primary antibody was diluted at 1:200 and incubated with 3% BSA in TBST 
buffer at 4 ºC overnight. PVDF membranes were then washed in TBST buffer 
for 15 min, followed by 1 h incubation time with hypoxanthine-guanine 
phosphoribosyl-transferase (HPRT)-linked secondary antibody (1:5000) at 
room temperature on a rocking platform (Stuart Scientific) for 1 h. Enhanced 
Chemiluminescence was detected using x-ray film.
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2.15 Confocal microscope cell imaging 
Cells were seeded on a square glass cover slip at a density of 8x104 per 3 cm 
dish to reach 70-80% confluence. siRNAs were then transfected into FEK4 
and HaCaT cells and incubated for 48 h. After transfection, the cell culture 
media were aspirated from each well, and the cells were washed three times 
with PBS and fixed with 400 µl 4% paraformaldehyde in PBS for 10 min at 
room temperature. The fixed cells were permeabilised with 100% ice cold 
methanol for 2 min at -20ºC. After 2 min, methanol was aspirated and cells 
were then washed with PBS three times. The cell nucleus was then stained 
with 5 µg/ml final concentration of DAPI (4',6-diamidino-2-phenylindole, 
dihydrochloride) at room temperature for 20 min in the dark followed by three 
PBS washes. The coverslips were then removed from each well, left to dry, 
and then mounted on glass slides by using mounting medium (s3023, 
fluorescence Mounting medium, DAKO, UK) and left overnight to dry at room 
temperature in the dark. The cells were examined using a Carl Zeiss laser 
scanning microscope (LSM 510 META).  
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2.16 NADPH Oxidase activity assay 
NADPH oxidase activity was detected by using the lucigenin assay. 
2.16.1 Principle 
Lucigenin (bis-N-methylacridinium dinitrate) (LC2+) has been used as a 
luminescent indicator of superoxide production. 
Addition of superoxide to the free radical gained with the reduction of lucigenin 
(LC. +), forms an unstable dioxetane, which in turn cleaves to produce N-
methylacridone in the excited state and this is where the luminescence occurs. 
However, the reducing agents such as alkaline can also induce luminescence. 
Thus lucigenin is not specific to superoxide. 
2.16.2 Procedure 
Cells were seeded at a density of 8x104 per 3 cm plates for 3 nights to reach 
a confluence of 80%. On the day of treatment, cells were irradiated with 
different UVA doses, and then cells were collected and centrifuged at 1,000 
rpm for 5 min. Cells were re-suspended with 0.5 ml lysis buffer (KH2PO4, 
20mM; EDTA, 0.5 mM; PMSF, 0.1%; tablet inhibitor) (Roche) and then 
transferred to an eppendorf tube, sonicated for 14s on ice (Rapidis 300, 
Ultrasonics, UK). After sonication, cells were centrifuged at 13,000 rpm for 5 
min at 4 ºC (Biofuge 13, Heraeus instrument). The supernatant was collected 
after the spin and the protein content was quantified by using the Bradford 
assay. 1 µg protein was added to the assay buffer containing 100 µM NADPH 
and 500 µM lucigenin. The assay buffer was then incubated in a water bath at 
37 ºC for 10min then put on ice. The luminescence generated by superoxide 
anion was measured by using an illuminometer (TD20/20, Turner Biosystem).
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2.17 Statistical analysis 
Data are expressed as mean ± the standard error of the mean (SEM), and 
statistical significance of the results was determined by one-way analysis of 
variance followed by the student t-test, with statistical significance set at 
p<0.05. 
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Chapter 3. Results 
Part : Potential protection of human skin cells against cell damage/inactivation 
via UVA-induced HO-1 
As mentioned in the introduction, protection against UVA-induced cellular 
damage in human skin cells is at least partially mediated by HO-1. A previous 
study (Raval et al., 2012) in this laboratory proved that Bach1 is involved in 
HO-1 induction in UVA irradiated FEK4 cells, and Bach1 inhibition increased 
the level of UVA-induced HO-1. Based on this study, we wanted to further 
examine whether Bach1 inhibition is involved in the protection process. In 
order to do this, the cell viability of UVA-irradiated FEK4 cells with siRNA of 
Bach1 (siBach1) pre-treatment was first of all checked by two cytotoxicity 
measuring assays with the potential to detect a role of Bach1 in protecting 
UVA-irradiated human skin fibroblasts: the MTS and LDH assays. We 
expected that there would be less cytotoxicity after UVA irradiation with 
siBach1 pre-treatment. 
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3.1 Silencing of Bach1 leads to no strong effect on cytotoxicity following UVA 
irradiation. 
The dehydrogenase enzyme activity of FEK4 cells was determined 4h 
following UVA irradiation using the MTS assay. The absorbance is directly 
proportional to the enzyme activity. Unexpectedly, the Bach1 siRNA has a 
strong and significant effect on the un-irradiated control cells and appears to 
have affected enzymatic activity (Figure 9). UVA does result in significant 
reduction in enzymatic activity after 250 kJ/m2 and 400 kJ/m2 but there does 
not appear to be a significant difference between UVA treated cells with or 
without scrambled (sb) or Bach1 targeted siRNAs. 
In view of the inconclusive results 4h after irradiation, dehydrogenase 
enzymatic activity of FEK4 cells was also determined 24h following UVA 
irradiation using the MTS assay with and without treatment with Bach1 siRNA. 
A higher concentration (20 nM) of siRNAs as well as a higher UVA dose was 
used in this experiment. The enzyme activity was reduced in a dose-
dependent manner following UVA irradiation, with significant reduction at the 
500 kJ/m2 dose level; however, silencing of Bach1 had no effect on the cell 
viability (Figure 10). The results described in this section so far indicate that 
although Bach1 appears to be involved in UVA-induction of HO-1, this protein 
does not seem to protect against UVA induced cellular damage in human skin 
fibroblasts. 
However, it is possible that in contrast to the results (Tyrrell and Pidoux, 1988) 
seen using inactivation of colony-forming activity as a viability measurement, 
UVA reduced viability as measured by the MTS assay is not redox dependent 
(i.e. cellular oxidative damage induced by UVA is not detected by the MTS 
assay). To further understand this, we next performed glutathione depletion in 
FEK4 cells and measured reduced viability using the MTS assay following 
UVA irradiation. 
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Figure 9 MTS assay of FEK-4 cells pre-treated with siBach1 (4h) following 
UVA irradiation with doses of 250 and 400 kJ/m2 of UVA. FEK-4 cells were 
transfected with or without siBach1 and seeded onto 24 well plates 48h before 
UVA irradiation as described in Materials and Methods. The MTS assay was 
performed after 4h incubation. The values of untreated cells were set to 100% 
and other values were normalized as a percentage of this control. Data shown 
are mean ± SEM (n=3).  
** p<0.01, *** p<0.001 significant difference when compared to untreated FEK 
control cells. 
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Figure 10 MTS assay of FEK-4 cells pre-treated with or without siBach1 for 
48h and measurements taken 24h following UVA irradiation at a series of 
doses (n=3). FEK-4 cells transfected with/without siBach1 were seeded onto 
the 24 well plates 48h before UVA irradiation. The MTS assay was performed 
after 24h incubation. Data shown represents mean values ± SEM.  
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3.2 Glutathione depletion of FEK4 cells by treatment with BSO results in a 
higher cytotoxicity following UVA irradiation. 
It has been proven that there is a direct correlation between the levels of 
sensitivity to UVA and cellular GSH content (Tyrrell and Pidoux, 1988) and 
that endogenous glutathione protects skin fibroblasts against UVA-induced 
cell damage (Tyrrell and Pidoux, 1986). Earlier studies had shown that 
depletion of cellular glutathione levels in UVA irradiated human skin cells led 
to lethal damage including the damage induced by oxidative stress. The 
reduced cell viability induced by this damage has been measured and 
confirmed by colony forming assay, but it is unknown whether this lethal 
damage can be detected by the MTS assay. To answer this question, we 
performed the same treatment in FEK4 cells (i.e. UVA irradiate FEK4 cells 
following glutathione depletion), and the MTS assay was used for measuring 
the cell viability.  
FEK4 cells were pre-treated with D,L-buthionine-S,R-sulphoximine (BSO) for 
glutathione depletion and the reduction in viability following UVA irradiation 
was measured using the MTS assay. The results in Figure.11 show the 
inactivation of FEK4 cells as a function of UVA dose. Notably, after 100 and 
150 kJ/m2 UVA, the viability in glutathione depleted cells was significantly 
reduced compared with untreated cells. This result is consistent with previous 
findings (Lautier et al., 1992) that upon UVA irradiation, there was an 
inactivation of colony forming ability in glutathione depleted cells compared to 
non-depleted cells. 
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Figure 11 MTS assay to measure inactivation of cultured skin fibroblasts by 
UVA irradiation with and without pre-treatment with BSO. BSO (20 µM) was 
added to FEK-4 cells 18h before UVA treatment. The MTS assay was carried 
out as described (Materials and Methods). All data points are mean values 
from three independent experiments and are shown as mean ± SEM. The 
Student t-test was used to evaluate the statistical significance (p<0.05) of each 
data point. 
* (p<0.05), ** (p<0.01), *** (p<0.001) when compared to non-irradiated control 
cells. 
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Since this result showed that the change in response to UVA as a result of 
glutathione depletion could also be measured by the MTS assay, we conclude 
that UVA-induced oxidative damage is detectable by the MTS assay. The 
results in Figure 11 using the MTS assay will therefore also reflect the 
oxidative damage sector. Taken together, the results of Bach1 inhibition 
experiments from this section provide evidence that silencing of Bach1 does 
not influence the viability of FEK4 cells (i.e. protect) following UVA damage. 
UVA-induced cellular damage generally initiates with lipid peroxidation which 
consequently leads to membrane damage. In view of the above results 
concerning cell viability in Bach1 inhibited FEK4 cells (as measured by the 
MTS assay), we speculated whether Bach1 inhibition could protect FEK4 cells 
against UVA-induced damage at the membrane level. Thus, membrane 
damage as measured by the LDH assay was employed next in UVA-irradiated 
FEK4 cells in this study to determine if silencing of Bach1 could protect the 
cells against UVA-induced membrane damage.
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3.3 Silencing of Bach1 does not result in lower membrane damage in FEK4 cells  
LDH released as a result of membrane damage to cells following UVA 
irradiation was measured using the LDH assay as described in Materials and 
Methods with and without pre-treatment with siBach1. The results in Figure 12 
showed a higher LDH release from UVA irradiated FEK4 cells compared with 
the non-irradiated control cells. The level of LDH release is 3 fold that of non-
irradiated control cells after 250 kJ/m2 UVA irradiation, and then slightly 
declined at 400 kJ/m2. With siBach1 pre-treatment, the UVA-induced LDH 
release level was strong in UVA irradiated (250 kJ/m2) cells. Surprisingly, the 
cells treated with scrambled siRNA (sisb) also lowered the level of UVA-
induced LDH release at both UVA doses. sisb RNA has no significant effect 
on the LDH release level in unirradiated FEK4 cells. This result revealed that, 
although siBach1 treatment decreased the higher level of LDH release 
following UVA irradiation, and therefore appears to protect FEK4 cells from 
UVA induced membrane damage, this is an artefact since the sisb treated 
control cells show similar effects.  
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Figure 12 LDH release in FEK4 cells with or without siBach1 (for 48h) 
treatment 4h following UVA irradiation at two doses (250 and 400 kJ/m2). The 
relative levels of LDH release were calculated as the proportion of LDH activity 
released from cells in the total LDH activity (LDH activity released from cells + 
LDH activity released from medium). The value of FEK4 control cells was set 
to 1, and all the other values were normalized to this value. Data shown are 
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Based on the data shown in Figures 9-12, the siBach1 treatment neither  
increased the UVA inactivated FEK4 cellular viability as measured by the MTS 
assay nor protected the cells against UVAinduced membrane damage as 
measured by the LDH assay. The results therefore indicate that Bach1 
inhibition has no protective effect against UVA-induced cellular damage, 
although it increases HO-1 induction. Nevertheless, it is also possible that the 
Bach1 inhibition is not sufficient to protect against UVA-induced damage at the 
level of viability or at the membrane damage level, but may be involved in a 
protective pathway at a more sensitive level, for example: ROS generation. To 
further explore this, ROS generation was then measured in FEK4 cells with 
siBach1 treatment followed by UVA irradiation. 
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3.4 Effect of siBach1/siHO-1 on ROS generation after UVA irradiation 
Bach1 binds to the HO-1 gene promoter and suppresses HO-1 gene 
expression (Sun et al., 2002). Okada and co-workers (Okada et al., 2010) have 
shown that in keratinocytes, lowering of Bach1 levels led to a higher level of 
HO-1 gene expression following H2O2 treatment, but did not lower the ROS 
generation by H2O2. The ROS level was higher in Bach1 depleted 
keratinocytes. On the other hand, when keratinocytes overexpressed Bach1, 
the HO-1 induction was completely abolished following H2O2 treatment, and 
the ROS level induced by H2O2 was enhanced compared with control cells 
(Okada et al., 2010).  
Since induction of HO-1 is believed to protect against oxidative stress, we 
questioned whether depletion of Bach1 protein in FEK4 cells could reduce 
UVA-induced ROS generation. In order to examine the role of Bach1 in the 
process of UVA-induced ROS generation, cells were treated with siBach1 
RNA 48 h before UVA treatment. Flow cytometry analysis was employed in 
this study using the ROS dye CM-H2DCFDA; the fluorescence intensity was 
analysed using flow cytometry (Materials and Methods).  
Curiously, the results (Figure 13A) showed more ROS generation in UVA 
irradiated cells that had been pre-treated with siBach1 RNA than in control 
cells. sisb RNA pre-treatment of FEK4 cells has less effect on UVA irradiated 
ROS generation, particularly at 200kJ/m2.  
Since the Bach1 gene depletion increased ROS generation in UVA treated 
skin fibroblasts, we next examined if HO-1 gene knock-down would influence 
the UVA-induced ROS generation pathway. HO-1 was targeted using HO-1 
siRNA in FEK4 cells and the ROS generation after UVA irradiation was 
measured by flow cytometry. Since previous experiments (Zhong et al., 2010) 
from this laboratory had shown that siHO-1 RNA did decrease the HO-1 
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protein expression level, the same siHO-1 RNA was employed in the current 
study for siHO-1 RNA treatments. The results (Figure 13B) revealed that siHO-
1 RNA pre-treated FEK4 cells exhibited slightly diminished ROS generation 
after UVA compared with the cells not treated with siRNA. However, the 
scrambled siRNA pre-treated cells also showed diminished ROS generation, 
so that there is no difference between sisb and siHO-1 treated cells. 
Page | 82  
Figure 13 Effects of siRNA silencing of either Bach1 or HO-1 on ROS 
generation following UVA irradiation in FEK4 cells. A: Modulation of ROS 
generation in FEK4 cells with and without siBach1 pre-treatment. B: 
Modulation of ROS generation in FEK4 cells with and without siHO-1 pre-
treatment. Values represent mean ± SEM (n=3). The siRNA for either Bach1 
or HO-1 was transfected into FEK4 cells which were incubated for 48 h before 
UVA irradiation. ROS generation was detected using a fluorescent dye (CM-
H2DCFDA) with flow cytometry. The data are shown as the fold change in ROS 
generation relative to non-irradiated FEK4 control cells. The value of ROS 
intensity for untreated FEK4 cells was set to 1 and all the other values were 
normalized to this control value. The student t test was used to evaluate the 
statistical significance of each data point. 
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Based on the results shown in Figure 13, silencing of Bach1 increased ROS 
generation especially at a higher UVA dose (200 kJ/m2), whereas silencing of 
HO-1 did not significantly alter the ROS level. We conclude that reduction of 
HO-1 does not have much influence on the level of ROS generation in FEK4 
cells following UVA treatment. However, depletion of the Bach1 gene 
increased ROS generation levels.  
HO-1 has generally been considered as having antioxidant activity, but there 
is evidence that it may be pro-oxidant in some circumstances (Kvam et al., 
2000; Li and Stocker, 2009), and possibly as a result of release of low-
molecular-mass iron (Kvam et al., 2000; Lamb et al., 1999). Free labile iron is 
the major Fenton catalyst and can lead to generation of ROS and enhance 
lipid peroxidation (Dennery et al., 1997). A previous study (Kvam et al., 2000) 
from this laboratory found that increased HO-1 activity increased the free labile 
iron level in HO-1 overexpressed cells which consequently led to a stronger 
sensitivity to UVA radiation. Therefore, a possible explanation for the increase 
in ROS when the HO-1 levels are enhanced by Bach1 depletion is that the 
increase in HO-1 leads to the release of iron. 
It is evident that oxidative stress induced p53-related senescence is regulated 
by Bach1 in murine embryonic fibroblasts (Dohi et al., 2008); in view of this 
evidence, another possible explanation for our result is that Bach1-regulated 
other genes involved in the process of increasing UVA-induced ROS 
generation. 
In summary, initially, since the reduction of Bach1 is the key to increasing HO-
1 induction, the main hypothesis of this study is that Bach1 would be involved 
in HO-1 mediated events. Thus, we predicted that knocking down of Bach1 
would lead to enhanced protection against skin cell damage via UVA induce 
HO-1 induction. However, the results obtained from this section revealed that 
reducing Bach1 increased HO-1 induction, but that there is no enhancement 
of protective effects against UVA-induced cell damage at either the membrane 
damage or cell viability level. The glutathione depletion experiments result 
provide the evidence that viability as measured by MTS assay included the 
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oxidative damage sector and therefore leads to the conclusion that Bach1 
reduction is insufficient to enhance protection against cell damage by UVA 
irradiation via the HO-1 induction pathway (i.e. it is independent of the 
oxidative pathway). The results also indicate the HO-1 reduction does not 
influence ROS generation by UVA irradiation.  
Taken together, these findings provide evidence that Bach1 inhibition is 
involved in the response to UVA events (i.e. HO-1 induction, ROS generation) 
but is not involved in protecting skin fibroblasts against UVA-induced cell 
damage.  
In this part, we hypothesised that as a key factor in HO-1 regulation, Bach1 
would be involved in HO-1 mediated events (i.e. knocking out Bach1 will 
enhance the protection of UVA-induced cellular damage). Therefore, we 
performed a series of experiments with Bach1 knock down treatment in UVA 
irradiated cells aimed to prove whether Bach1 inhibition would enhance the 
protection. However, all the data gained from this part showed us that Bach1 
inhibition is not protective against UVA-induced cytotoxicity in human skin 
fibroblasts. As the UVA-mediated HO-1 induction appears to protect against 
cellular damage by a different pathway, we considered it important to find out 
the cellular source of UVA-induced damage. Since excessive ROS generation 
has been considered the major reason for damage, the source of UVA-induced 
ROS generation became our next research target. As a major source of ROS 
formation, NADPH oxidase has been extensively studied recently and there is 
evidence to show that NADPH oxidase (NOX) is the major source of UVA-
induced ROS generation in cultured human keratinocytes (Valencia and 
Kochevar, 2008). Thus, the involvement of NOX in UVA-mediated ROS 
generation in human skin cells is the main purpose of the experiments that 
follow.
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Part : The Role of NADPH oxidase (NOX) in the response of human skin cells 
to UVA irradiation ROS generation 
In this part, we hypothesized that NOX may be involved in the response of 
UVA-mediated ROS generation and that NOX would be activated in human 
skin cells in response to ROS induction by UVA irradiation. We therefore 
predict that induction of ROS will be inhibited by NOX inhibition. To investigate 
this, we performed experiments that included an investigation of the ROS 
generation following NOX inhibition in UVA-irradiated human skin cells as 
measured by flow cytometry. NOX activity following UVA treatment has been 
measured by the lucigenin assay to further understand the role of NOX in the 
process of UVA-mediated ROS generation. 
3.5 Comparisons of ROS generation in skin cells after UVA irradiation 
In order to investigate whether NOX is involved in the process of UVA-
mediated ROS generation, the first step was to determine the influence of NOX 
on the ROS induction by UVA. ROS generation was detected in primary 
human skin fibroblasts (FEK4) as well as human immortalized keratinocytes 
(HaCaT) using flow cytometry analysis with CM-H2DCFDA dye as described 
in Materials and Methods. UVA irradiation generated significant induction of 
intracellular ROS in both these two types of skin cell lines but to different levels.   
The ROS induction was measured after UVA irradiation in FEK4 cells as well 
as keratinocytes (Figure 14). Following UVA treatment, fluorescence intensity 
of ROS induction in FEK4 cells increased in a UVA dose dependent manner 
(Figure 14A). The fold change of ROS generation as measured by 
fluorescence intensity over non-irradiated FEK4 cells was by 2.5 fold at 150 
kJ/m2 and by 3.5 fold at 200 kJ/m2. A similar trend occurs in HaCaT cells 
(Figure 14B); ROS generation increased up to nearly 3 fold over non-irradiated 
cells after 150 kJ/m2 but declined slightly at 200 kJ/m2. This decline may be 
due to damage to proteins that generate ROS by higher doses of UVA 
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irradiation. These results are consistent with the previous results observed for 
ROS generation after UVA irradiation in human skin tissue (Ou-Yang et al., 
2004; Tyrrell, 2012). The results shown in Figure 15 showed a much larger 
induction of ROS in skin fibroblasts (FEK4 cells) compared with skin 
keratinocytes (HaCaT cells).
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Figure 14 A: ROS generation after UVA irradiation of FEK4 cells. B: ROS 
generation after UVA irradiation of HaCaT cells. ROS generation was 
measured by flow cytometry after 25 min incubation with a derivative of the 
fluorescein ROS dye (CM-H2DCFDA) as described in Materials and Methods. 
The results of relative ROS fluorescent intensity were expressed as the fold 
change relative to normalized control FEK4 cells and HaCaT cells (mean ± 
SEM). Statistics were carried out using the student t-test (n=3).  
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Figure 15 A direct comparison of ROS generation in FEK4 cells () and HaCaT 
() cells. ROS generation was measured by flow cytometry after 25 min 
incubation with a derivative of the fluorescein ROS dye (CM-H2DCFDA) as 
described in Materials and Methods. The results of relative ROS fluorescent 
intensity were expressed as the fold change relative to normalized control 
FEK4 cells. The value (mean ± SEM) of ROS intensity for untreated FEK4 cells 
was set to 1 and all the other values were expressed relative to this value. The 
student t test was used to evaluate the statistical significance of each data 
point. 
  P<0.05,     p<0.001 when compared to UVA treated FEK4 cells. 
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In summary, UVA irradiation of human skin cells results in dose-dependent 
ROS induction and differs between FEK4 cells and HaCaT cells. The basal 
level of ROS in FEK4 cells is significantly higher than that in HaCaT cells; UVA 
irradiation also leads to significantly stronger ROS induction in FEK4 
fibroblasts compared with HaCaT cells.  
The NOX activity after UVA irradiation was examined in the following section 
in order to further investigate if NOX is involved in UVA-mediated ROS 
generation as well as to determine the relative importance of NOX subunits 
(i.e. NOX1 and NOX4). 
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3.6 A comparison of UVA activated NOX activity in cultured skin cells following 
UVA irradiation 
NOX activation was observed in human keratinocytes (Valencia and Kochevar, 
2008). We have now examined whether NOX is also activated in cultured 
human skin fibroblasts, and compared the result with those obtained in HaCaT 
cells (immortalized keratinocytes). The modulation of NOX activity in skin cells 
following UVA treatment was determined in this section.  
Firstly, we determined the dose response as well as the time response of the 
appearance of NOX activity after UVA irradiation of cultured human skin 
fibroblasts. The results in Figure 16 show that in skin fibroblasts (FEK4 cells), 
NOX activity was activated as a function of dose (Figure 16A) and time (Figure 
16B) after UVA treatment. The results indicate that a substantial NOX activity 
is apparent when measurement is done as soon after irradiation as possible. 
A 3-fold increase in activity was seen within 5 min and the activity declined 
slightly over the next 30 min. The response of NOX activity to changes in UVA 
dose in HaCaT cells was also determined in this study, and NOX activity was 
observed after 150 kJ/m2 UVA treatment (Figure 17). This activity increased 
with increase in UVA dose. 
The results in Figure 18 are a comparison of NOX activity between FEK4 cells 
and HaCaT cells. NOX was strongly activated in FEK4 cells in a dose 
dependent manner at doses up to 150 kJ/m2. From 200 kJ/m2, the pattern of 
dose response to UVA activation was quite different between fibroblasts and 
immortalized keratinocytes. In fibroblasts, NOX activity started to drop down 
to 3 fold compared to control cells. For HaCaT cells, little NOX activation was 
observed at doses less than 150 kJ/m2 and the highest activation (7 fold 
compared to control) was observed at 200 kJ/m2. This result demonstrated 
that NOX is activated following UVA irradiation to different extents in different 
skin cell types. 
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The results in this section showed that NOX is activated following UVA 
irradiation in both FEK4 and HaCaT cells. The potential contribution of different 
subunits of NOX in both cell types was then investigated.   
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Figure 16 A: The dose response of NOX activation following UVA treatment of 
FEK4 cells. B: The time-dependent response of NOX activation after UVA 
irradiation of FEK4 cells. FEK4 cell lysates were incubated with lucigenin and 
NADPH for 10 min and superoxide generation was determined by measuring 
photoemission (using an illuminometer). Values in the bar represent the 
relative light emission. The Data shown are mean ± SEM (n=3). The value of 
NOX activity for untreated FEK4 cells was set to 1; other values were 
normalized to this value. The student t test was used for statistical significance 
of each data point. Data shown are mean ± SEM (n=3-4). 
 *p<0.05 when compared with unirradiated FEK4 control cells. 
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Figure 17 Dose response of NOX activation following UVA irradiation of 
HaCaT cells over a range of doses; HaCaT cell lysates were incubated with 
lucigenin and NADPH for 10 min and super oxide generation was determined 
from photoemission levels using an illuminometer. Data shown are mean ± 
SEM (n=3) relative to controlled HaCaT cells. The student t test was used for 
statistical significance of each data point. 
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Figure 18 A comparison of UVA activation of NOX activity in FEK4 and HaCaT 
cells. The value for the FEK4 control cells without UVA irradiation was set to 
1 and other values were expressed relative to this value. Data shown are mean 
± SEM (n=3). The student t test was used to determine statistical significance 
of each data point. 
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3.7 A comparison of UVA activation of NOX proteins (NOX1 and NOX4) in 
cultured skin cells following UVA irradiation 
The results described above show that NOX is activated by UVA irradiation in 
both skin cell lines used although with different dose-dependencies. 
Considering that the NOX family includes 7 classes of proteins, we next sought 
to identify which NOX family members were involved in the response in each 
cell type. The proteins potentially involved in this response were investigated 
next in this study in order to further answer the question as to whether NOX is 
involved in the UVA-mediated ROS response. From the literature, we 
predicted that NOX1 and NOX4 are most likely to be involved in the UVA 
activation of NOX. We therefore, studied the appearance of both NOX1 and 
NOX4 subunits after UVA irradiation in both skin cell lines using western blots. 
The result (Figure 19 and Figure 20) showed that both NOX1 and NOX4 
protein were involved in the activation but to different extents. 
The results (Figure 19) revealed that basal levels of NOX1 protein expression 
are 3 fold greater in HaCaT cells than in fibroblasts. Following UVA irradiation 
of FEK4 cells, NOX1 protein was up-regulated up to 1.5 fold (100 kJ/m2) 
compared with control cells. Meanwhile, in HaCaT cells, NOX1 expression did 
not change much upon UVA treatment. These results indicate that NOX1 
contributed more to NOX activation in UVA-induced FEK4 cells. 
The NOX4 subunit has also been extensively studied relative to the other 
family members. The activation of NOX4 in fibroblasts has been related to 
oxidative stress (Goyal et al., 2005; Schroder et al., 2012). So it was logical to 
examine NOX4 expression in cultured human skin cells following UVA 
irradiation. The results shown in (Figure 20) are consistent with the possibility 
that NOX4 contributes to NOX activation in HaCaT cells, but not in FEK4 cells. 
Page | 96  
Figure 19 A comparison of NOX1 protein expression in two skin cell types 
(FEK4 and HaCaT) after UVA irradiation. NOX1 protein expression in skin 
cells was measured by western blot as described in Materials and Methods. 
Values in the column represent the optical density of each band as detected 
by chemiluminescence and analysed using ImageJ. The results are shown as 
the mean ± SEM (n=3). The value for untreated FEK4 control cells was set to 
1 and other values were expressed relative to this value. The student t test 
was used to determine the statistical significance of each data point. 
*p<0.05 when compare to untreated FEK4 cells. 
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Figure 20 A comparison of NOX4 protein expression in two skin cell types 
(FEK4 and HaCaT) after UVA irradiation. NOX4 protein expression in skin 
cells was measured by western blot as described in Materials and Methods. 
Values in the column represent the optical density as detected by 
chemiluminescence and analysed using ImageJ. The results are shown as the 
mean ± SEM (n=3). The value for untreated FEK4 control cells was set to 1 
and other values were expressed relative to this value. The student t test was 
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Basal level of NOX4 protein expression was not significantly different between 
the two skin cell types. However, following UVA radiation treatment, NOX4 
expression in HaCaT cells was up-regulated 2 fold compared with FEK4 cells. 
These results indicate that NOX4 contributes more to NOX activation in UVA-
irradiated HaCaT cells than in UVA-irradiated fibroblasts. 
In summary, NOX1 and NOX4 protein expression are up-regulated to different 
extents in these two skin cells lines, but NOX1 and NOX4 subunits are clearly 
both involved in the UVA-induced NOX activation process.  
To further investigate whether NOX is involved in the process of UVA-induced 
ROS generation, NOX inhibition experiments were carried out using NOX 
inhibitors (diphenylene iodonium, plumbagin and siRNAs for NOX1 and 
NOX4). In this way we could determine the effect of inhibition of NOX on UVA-
induced ROS generation.
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3.8 Effects of NOX inhibitors on UVA-mediated ROS generation. 
As mentioned in the introduction, diphenylene iodonium (DPI) has been widely 
used as a general NOX inhibitor and plumbagin has been used as a NOX4 
inhibitor. Therefore, DPI is employed in this study for general NOX inhibition 
and plumbagin was initially used for inhibiting NOX4. Inhibiting NOX using DPI 
abolished the UVA-induced ROS generation.  
However, treatment with plumbagin led to more complex effects and siRNAs 
for both NOX1 and NOX4 were also employed in this study in order to achieve 
more specific inhibitory effects.  
Effect of DPI pre-treatment on UVA-mediated ROS generation in skin cells 
Valencia and Kochevar (2008) have shown that DPI pre-treatment of skin 
keratinocytes decreased UVA-induced ROS generation event at the lowest (1 
µM) DPI concentration used. This concentration was used for the remaining 
experiments. We have found that DPI pre-treatment also reduced UVA-
induced ROS generation in skin fibroblasts, a result consistent with NOX 
involvement in UVA-induced ROS generation in fibroblasts.  
NOX was inhibited using DPI and the inhibitory effect on ROS generation in 
cultured human skin fibroblasts (FEK4 cells) was then determined by flow 
cytometry. The results (Figure 21) showed that in DPI pre-treated FEK4 cells, 
UVA induced ROS generation was completely prevented even at the lowest 
DPI concentration (1 µM). After 250 kJ/m2, ROS were induced to 2 fold higher 
levels than unirradiated control cells. With DPI pre-treatment, at 
concentrations as low as 1 µM, the ROS generation by UVA was diminished 
to basal level. The same effect was found in the cells with the higher 
concentrations (i.e. 5, 10 and 20 µM) employed in this study. The UVA-induced 
ROS level dropped slightly below the basal level at 20 µM. The maximum 
concentration used (20 µM) only slightly affected the basal ROS level of un-
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irradiated cells. In addition, interestingly, we found that ROS generation was 
cell confluency dependent (with or without DPI treatment) following UVA 
irradiation of skin fibroblasts. 
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Figure 21 ROS generation in UVA irradiated FEK4 cells following pre-
treatment with DPI. FEK4 cells were pre-treated with different concentrations 
of DPI for 1 h before UVA treatment. ROS generation was measured by Flow 
cytometry after 25 min incubation with a derivative of the fluorescein ROS dye 
(CM-H2DCFDA) as described in Materials and Methods. The values represent 
mean ± SEM (n=3). The value of ROS intensity for untreated FEK4 cells was 
set to 1; all the other values were expressed relative to this control.  
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A skin cell confluency effect on UVA-induced ROS generation (with or without 
NOX inhibition) 
During this study, we also found an interesting phenomenon concerning a 
confluency effect on ROS generation in skin fibroblasts treated with UVA (with 
or without DPI pre-treatment). The results show that the level of ROS 
generation following UVA irradiation of skin fibroblast is confluency dependent. 
FEK4 cells were seeded at two different starting numbers in 3 cm dishes on 
the same day before UVA treatment to reach a different density. The results 
(Figure 22) showed that ROS were induced by UVA treatment at both 
confluences. However, irradiation of cells with 100 kJ/m2 UVA at the higher 
confluence generated less ROS than UVA irradiation at the lower confluence 
but the effect was the opposite at 200 kJ/m2.  
Notably, with the DPI treatment in subconfluent cells (i.e. 50%), the ROS 
induction increased with increase in UVA dose (Figure 23). On the day of 
treatment, the subconfluent FEK4 cells were treated with or without DPI 
followed by UVA irradiation. The results showed that in FEK4 cells pre-treated 
with DPI at a lower density (Figure 23), the increase in ROS induction by UVA 
is higher than in the non-DPI pre-treated FEK4 cells. Consistent with the 
results at lower density, FEK4 cells are more sensitive to UVAinduced ROS 
generation; one possible explanation for this is that DPI enhances the 
sensitivity to ROS generation when the cells are under sensitive conditions. 
There is evidence for DPI induced ROS generation at higher concentrations 
(5 µM) and longer durations (1h) in human promyelocytic leukaemia cells (Li 
et al., 2003b).  
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Figure 22 The effect of confluence on ROS induction after UVA irradiation of 
FEK4 cells. ROS generation was measured by flow cytometry after 25 min 
incubation with a derivative of the fluorescein ROS dye (CM-H2DCFDA) as 
described in Materials and Methods. Values represent mean ± SEM. The data 
are shown as the relative change in ROS generation relative to non-irradiated 
FEK control cells grown to the higher density (80%). The value of ROS 
generation for untreated FEK4 cells (80% density) was set to 1 and all the 
other values were expressed relative to this value. The Student t test was used 
to evaluate the statistical significance of each data point. 
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Figure 23 ROS generation after UVA irradiation of FEK4 cells at the lower 
density (50%) with DPI (1 µM) pre-treatment. The values represent mean ± 
SEM (n=3). ROS generation was measured by flow cytometry after 25 min 
incubation with a derivative of the fluorescein ROS dye (CM-H2DCFDA) as 
described in Materials and Methods. The value of ROS generation for 
untreated FEK4 cells (50% density) was set to 1 and all the other values were 
expressed relative to this value. The Student t test was used to evaluate the 
statistical significance of each data point.  
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In summary, a general NOX inhibitor (DPI) decreased UVA-induced ROS 
generation in FEK4 cells. As NOX inhibition using the general inhibitor DPI 
abolished the UVA-induced ROS, it demonstrated that NOX may also be 
involved in the UVA-mediated ROS generation in skin fibroblasts. Since UVA-
induced ROS generation is also inhibited by the NOX inhibitor DPI in cultured 
human skin fibroblasts, we questioned which NOX family protein may 
contribute to this process. As the earlier results of this study showed that both 
NOX1 and NOX4 contribute to UVA-induced NOX activation, we focused on 
these two NOX proteins to determine if they are involved in UVA-induced ROS 
generation. The effect of the NOX4 inhibitor (plumbagin) on ROS generation 
in FEK4 cells treated with UVA was first measured by flow cytometry. 
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Inhibiting effects of NOX4 inhibitor (plumbagin) pre-treatment on UVA-
mediated ROS generation in skin. 
Among the 7 NOX classes of proteins, NOX1 and NOX4 have been the most 
widely studied subunits in relation to ROS events so far. According to previous 
studies (Valencia and Kochevar, 2008), NOX1 was considered as a major 
source of ROS generation following UVA irradiation of skin keratinocytes; 
NOX4 has been shown to be involved in the ROS generating events in human 
dermal fibroblasts (Rossary et al., 2007). Based on these findings, the role of 
NOX1 and NOX4 subunits in UVA-mediated ROS generation was determined. 
We inhibited NOX4 using plumbagin in cultured human skin cells to determine 
NOX4 involvement in UVA-induced ROS generation. The results in plumbagin 
pre-treated skin cells that were treated with UVA irradiation were complex. 
Skin cells were pre-treated with plumbagin and then UVA irradiated. The cells 
were then incubated with CM-H2DCFDA and ROS generation was measured. 
Surprisingly, there is a significant induction of ROS generation in both 
plumbagin pre-treated non-irradiated FEK4 cells (Figure 24) and HaCaT 
(Figure 25) cells. Nevertheless, plumbagin considerably reduced the UVA-
induced ROS induction in both skin cell lines upon UVA treatment. 
In FEK4 cells (Figure 24), ROS induction was observed as expected after UVA 
treatment in non-plumbagin treated cells compared to control cells. However, 
in non-irradiated plumbagin pre-treated cells, substantive ROS generation was 
induced by the plumbagin pre-treatment alone. Nevertheless, with UVA 
treatment, ROS induction by UVA was considerably reduced to below basal 
levels. Similarly, in HaCaT cells (Figure 25), ROS induction was again 
observed in non-plumbagin treated cells compared to control cells. In un-
irradiated HaCaT cells, plumbagin strongly induced ROS generation even at 
the lowest concentration (1 µM). This result established that plumbagin alone 
induced ROS in skin cells although to different extents. The results indicate 
that although plumbagin is inhibiting ROS generation by UVA, it also induced 
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ROS generation by itself, which will confound interpretation. In order to further 
explore this phenomenon, ROS generation in non-irradiated skin cells treated 
with plumbagin as well as the reduction of UVA-induced ROS by plumbagin 
was examined using flow cytometry.  
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Figure 24 ROS generation after UVA irradiation of FEK4 cells with and without 
plumbagin pre-treatment. FEK4 cells were pre-treated with and without 
plumbagin for 10 min followed by UVA irradiation. ROS generation was 
measured by flow cytometry after 25 min incubation with a derivative of the 
fluorescein ROS dye (CM-H2DCFDA )The values of ROS fluorescent intensity 
were expressed relative to control FEK4 cells Data are shown as the mean ± 
SEM (n=3). Statistical analysis was performed by the Student t test.  
** p< 0.01 when compared with untreated FEK4 control cells. 
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Figure 25 ROS generation after UVA irradiation of HaCaT cells with and 
without plumbagin pre-treatment. HaCaT cells were pre-treated with and 
without plumbagin for 10 min followed by UVA irradiation. ROS generation was 
measured by flow cytometry after 25 min incubation with a derivative of the 
fluorescein ROS dye (CM-H2DCFDA). The results of ROS fluorescent intensity 
were expressed relative to control HaCaT cells. Data are shown as mean ± 
SEM (n=3). Statistical analysis was performed by the student t-test.  
* p< 0.05 significant difference when compared with untreated FEK4 control 
cells. 
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Analysis of apoptosis and necrosis in UVA irradiated cells which have been 
pre-treated with plumbagin  
Plumbagin treatment of cells results in a complex response with an expected 
effect on UVA activation of ROS. Plumbagin treated skin cells induced ROS 
generation in the absence of UVA treatment so that the analysis of the effect 
of pre-treatment with plumbagin or UVA induced ROS is more complicated. In 
order to find out whether plumbagin induced ROS leads to skin cell damage, 
the level of skin cell death (i.e. apoptosis and necrosis) was analysed by dual 
stain flow cytometry.  
Apoptosis and necrosis are two pathways of cell death. Apoptosis often starts 
with cell membrane damage but with membrane integrity maintained, necrosis 
starts with loss of the membrane integrity. Dual staining with annexin V-FITC 
(AV) and propidium idodide (PI) were employed in this study to distinguish 
apoptotic from necrotic cells. As a nuclear binding dye, PI stains the nuclei of 
those cells that have lost their membrane integrity as a result of undergoing 
necrosis. As a protein dye, AV will bind to externalized phosphatidylserine 
when cells are in the early stage of apoptosis. 
Human cultured skin cells were pre-treated with plumbagin followed by UVA 
irradiation (150 kJ/m2); cells were then collected and stained with AV and PI 
for flow cytometry analysis. The results shown (Figure 26-29) represent the 
analysis of cell death by flow cytometry. The results are presented in two ways 
(dot plot graphs and data charts). Apoptotic and necrotic cell death are 
observed in FEK4 cells and HaCaT cells following plumbagin treatment both 
with and without UVA irradiation. 
FEK4 cells undergo increased necrosis after 2.5 µM plumbagin treatments 
alone whereas the apoptotic population is decreased (Figure 27). A lower 
concentration of plumbagin (1 µM) as well as UVA treatment increases 
necrosis of FEK4 cells. This necrosis increased further at higher 
concentrations of plumbagin (2.5 µM) pre-treatment; however, UVA induced 
apoptosis almost disappeared after 2.5 µM pre-treatment (Figure 27). Similarly, 
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in HaCaT cells (Figure 29), plumbagin pre-treatment alone led to increased 
necrosis (up to 59.2%) at higher plumbagin concentration (2.5 µM). At a lower 
concentration of plumbagin (1 µM) and with UVA treatment, the necrosis 
increased up to 77.3%. This necrosis dramatically increased further to 94.3% 
at a higher concentration of plumbagin (2.5 µM). Similar to FEK4 cells, the 
apoptosis almost disappeared after 2.5 µM pre-treatment (Figure 29).
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Figure 26 Flow cytometry analyses of plumbagin pre-treated FEK4 cells with 
and without UVA irradiation. FEK4 cells were pre-treated with and without 
plumbagin for 10 min followed by UVA irradiation (right column). FEK4 cells 
were dual stained with PI and AV before measurement. The percentage of 
apoptotic and necrotic cell death was scored by flow cytometry. The plots 
represent the fluorescence intensity of individual cells in the cell population. 
Numbers shown are the percentage of cells in each quadrant. In this study 
(n=1), PI positive (Q1) and AV positive cells (Q2) were considered necrotic 
cells; PI negative but AV positive cells were considered apoptotic cells (Q4). 
Both PI and AV negative cells were considered Live cells (Q3). PI-Area (PI-A) 
represent the PI fluorescence intensity.
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Figure 27 Flow cytometry analyses of plumbagin pre-treated FEK4 cells with 
and without UVA irradiation. The bars show the percentage of apoptotic and 
necrotic cells induced 4 h after UVA irradiation following plumbagin pre-
treatment of FEK4 cells. Data shown are as a percentage of total cells under 
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Figure 28 Flow cytometry analyses of plumbagin pre-treated HaCaT cells with 
and without UVA irradiation. HaCaT cells were pre-treated with and without 
plumbagin for 10 min incubation followed by UVA irradiation (right column). 
FEK4 cells were dual stained with PI and AV before measurement. The 
percentage of apoptotic and necrotic cell death was scored by flow cytometry. 
The fluorescence intensity of individual cells in the population is plotted. 
Numbers shown are the percentage of cells in each quadrant. In this study 
(n=1), PI positive (Q1) and AV positive cells (Q2) were considered as necrotic 
cells; PI negative but AV positive cells were considered apoptotic cells(Q4). 
Both PI and AV negative cells were considered live cells (Q3). PI-Area (PI-A) 
represent the PI fluorescence intensity. 
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Figure 29 Flow cytometry analyses of plumbagin pre-treated HaCaT cells with 
and without UVA irradiation (n=1). The bars show the percentage of apoptotic 
and necrotic cells induced 4 h after UVA irradiation following plumbagin pre-
treatment of HaCaT cells. Data shown are as a percentage of total cells under 
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To summarise, in skin fibroblasts, plumbagin alone induced ROS generation 
and led to necrosis. Plumbagin abolished UVA generated ROS and led to 
further necrosis. In HaCaT cells (as in FEK4), plumbagin strongly induced 
ROS generation at a lower concentration (1 µM) leading to necrosis. With UVA 
treatment, although plumbagin decreased the ROS generation, this reduction 
led to a stronger cell death. Thus, these results revealed that although 
plumbagin largely abolished UVA-induced ROS generation even under basal 
level, this reduction resulted in necrosis. 
The results obtained in the plumbagin treatment experiments demonstrate a 
toxic effect of plumbagin on UVA irradiated skin cells. They also showed that 
plumbagin decreased ROS induction by UVA irradiation and that this was 
unrelated to a protective effect.  
In this section, we provide evidence that a general inhibitor of NOX inhibits 
UVA-induced ROS generation. We hypothesised that NOX4 may contribute to 
this process, so that plumbagin treatment which would inhibit NOX4 would 
abolish the UVA-mediated ROS generation. However, the results of NOX4 
inhibition using plumbagin show effects of the drug itself which confounded 
interpretation. Based on these results and to further investigate the NOX 
subunits involved, small interfering RNA (siRNA) were employed for targeting 
NOX1 and NOX4 to achieve more specific NOX inhibitory effects.  
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3.9 Effect of NOX1/NOX4 gene knockdown on ROS generation after UVA 
irradiation of skin cells. 
Since both NOX1 and NOX4 protein expression are up-regulated in both skin 
cell types, the specific role of NOX1 and NOX4 protein in the process of UVA 
induced ROS generation was investigated using siRNA to knock down 
expression of each of the genes. First of all, the efficiency of knocking down 
each of the genes was examined in cultured skin cells using various 
parameters. 
Efficiency of siRNA knocking down of NOX1 and NOX4  
Human cultured skin cells were seeded and transfected with siRNAs, and then 
incubated for 48 h. The efficiency of the knock down using siRNAs for NOX1 
and NOX4 in cultured human skin cells (FEK4 and HaCaT) were detected at 
various levels which are: cellular level as measured by confocal imaging, 
protein expression level as measured by western blot and NOX enzymatic 
activity level as measured by NOX activity assay. The results showed high 
siRNA delivery efficiency at different levels in both skin cell types (Figure 30-
34). 
As shown in Figure 30, the efficiency of siRNA delivery into cells was 
measured by confocal imaging; the results showed that the siRNAs were 
successfully delivered into both FEK4 cells and HaCaT cells using the siRNA 
transfection method employed in this study (as described in Material and 
Methods). The fluorescent tagged sisb RNA was observed to localize inside 
the cells 48 h after transfection.  
The efficiency of siRNA in changing NOX activity level and protein level were 
also checked in this study and the results obtained are shown in Figure 31-34. 
In FEK4 cells, the NOX activity reduced to almost half of the untreated control 
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cell level after treatment of FEK4 cells with a mixture of siNOX1 + siNOX4 (48 
h) RNAs (Figure 31). We chose the 48 h incubation time for the remaining 
study. Treatment with siNOX1 or siNOX4 RNA individually already decreased 
NOX1 or NOX4 activity by 50% compared with the untreated control FEK4 
cells (Figure 32). Treatment with siNOX1 reduced the NOX1 protein 
expression level to 70% of the level in untreated cells (Figure 32A). Treatment 
with siNOX4 reduced the NOX4 protein expression level to 50% of the level in 
untreated cells (Figure 32B). 
In HaCaT cells, the NOX activity was reduced by more than half of the 
untreated control cells after treatment with siNOX1 alone and siNOX4 
treatment reduced the NOX activity to around 40% of untreated control cell 
levels (Figure 32B). This suggests that NOX1 and NOX4 contribute to NOX 
activity in HaCaT cells. Interestingly, neither siNOX1 nor siNOX4 significantly 
reduced the NOX1 or NOX4 protein expression levels (Figure 34). Silencing 
NOX1 and NOX4 genes may have different effects at the protein level and 
activity level. 
In summary, the results in this section showed that siRNA can be delivered 
successfully into skin cells using the transfection method employed in this 
study. Transfection of siNOX1 or siNOX4 RNAs using a similar methodology 
results in a large reduction of the activity and protein expression levels of 
NOX1 and NOX4, respectively. These results demonstrate the efficiency of 
the knock down approach in inhibiting the targeted subunits.  
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Figure 30 Confocal microscopy cell imaging of siRNA delivery in skin cells. A: 
siRNA delivery in FEK4 cells. A: siRNA delivery in HaCaT cells. Alexa Fluor 
647 or Cy5 labelled scrambled siRNA (5 nM) were transfected into FEK4 and 
HaCaT cells and incubated for 48 h; cells were then fixed and stained with 
DAPI nuclear stain after mounting on microscope slides. The confocal images 
were captured with an x60 oil lens of a Zeiss META 510 confocal microscope 
as described in Material and Methods. The fluorescent intensity detected in 
the confocal imaging shows siRNAs localized within the FEK4 and HaCaT 
cells. Blue is nuclear stained by DAPI, red is either Alexa Fluor 647 or Cy5 
labelled siRNA. 
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Figure 31 The effect on NOX activity of adding a mixture of NOX1 and NOX4 
siRNA to FEK4 cells as a function of transfection time. A mixture of siRNAs (5 
nM) for NOX1 and NOX4 were transfected into FEK4 cells and incubated for 
the indicated times (24, 48 and 72 h). NOX activity was then determined using 
the lucigenin assay as described in 2.11. Values in the bar represent the 
relative NOX activity with respect to untreated FEK4 cells. Data shown are 
mean ± SEM (n=3). The student t test was used for analysis of statistical 
significance of each data point. 
* p<0.05 significant difference from no siRNA treated FEK4 control cells. 
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Figure 32 The effect of adding NOX1 or NOX4 siRNAs on the NOX activity of 
cultured skin cells. A): siNOX1 or siNOX4 effect on NOX activity in FEK4 cells. 
B): siNOX1 or siNOX4 effect on NOX activity of HaCaT cells. siRNAs for NOX1 
or NOX4 were transfected into cells and incubated for 48 h. NOX activity was 
then determined using the lucigenin assay as described in Materials and 
Methods. Values in the bar represent the NOX activity relative to the untreated 
control cells (set to 1). Data shown are mean ± SEM (n=3). Other values were 
normalized to this value. The student t test was used for the analysis of 
statistical significance of each data point. 
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Figure 33 The effect of siNOX1 or siNOX4 on NOX1 and NOX4 protein 
expression in FEK4 cells. A: siNOX1 effect on NOX1 protein expression of 
FEK4 cells. B: siNOX4 effect on NOX4 protein expression of FEK4 cells. 
siRNAs for NOX1 or NOX4 were transfected into FEK4 cells and incubated for 
48 h. The NOX protein expression of each sample was determined by western 
blot. Values in the column represent the optical density as detected by 
chemiluminescence and analysed using ImageJ software. The results are 
shown as mean ± SEM (n=3). The values of protein expression are shown 
relative to the control. The student t test was used for analysis of statistical 
significance of each data point. 
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Figure 34 The effect of siNOX1 or siNOX4 on NOX1 and NOX4 protein 
expression in HaCaT cells. A: siNOX1 effect on NOX1 protein expression of 
HaCaT cells. B: siNOX4 effect on NOX4 protein expression of HaCaT cells. 
siRNAs for NOX1 or NOX4 was transfected into HaCaT cells and incubated 
for 48 h. The NOX protein expression of each sample was determined by 
western blot. Values in the column represent the optical density as detected 
by chemiluminescence and analysed using ImageJ software. The results are 
shown as mean ± SEM (n=3). The values of protein expression are shown 
relative to the control. The student t test was used for analysis of statistical 
significance of each data point. 
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Effect of siNOX on ROS generation after UVA irradiation. 
Based on the results of the siRNA transfection experiments, skin fibroblasts 
were treated with siNOX1 or siNOX4 and the ROS generated by UVA 
irradiation were detected by flow cytometry. The results (Figure 35 and Figure 
36) did not show any modification of ROS level following treatment with 
siNOX1 RNA, siNOX4 RNA or both in siRNA pre-treated FEK4 cells.  
As shown in Figure 35, although the transfection regent alone decreased ROS 
induction at a higher UVA dose (250 kJ/m2), the results showed further ROS 
reduction when the siRNA treatment was with the individual siRNA (i.e. 
siNOX1 or siNOX4). However, the reduction was also observed with 
scrambled siRNA treatment, and it is not very different from the effect of the 
targeted siRNA. Similarly, when the siRNA treatment was with the combined 
siRNA of NOX1 and NOX4 (Figure 36), UVA-induced ROS generation was 
reduced, but the same reduction was also observed after scrambled siRNA 
treatment.   
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Figure 35 The effect of NOX gene silencing on ROS generation by UVA 
irradiation of human FEK4 cells. siRNAs (for either NOX1 or NOX4) were 
added into FEK4 cells with transfection reagent according to the manufacturer 
s protocol, incubated for 48 h following UVA irradiation and then ROS 
generation was detected by flow cytometry. Data shown are mean ± SEM of 
three independent experiments. Values for ROS generation are expressed 
relative to untreated FEK4 cells. The student t test was used to evaluate the 
statistical significance of each data point.  
*p<0.05 when compared to untreated control cells.  
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Figure 36 The effect of NOX gene silencing (NOX1 and NOX4) on ROS 
generation by UVA irradiation of human FEK4 cells. A mixture of siRNA (for 
NOX1 and NOX4) was transfected into FEK4 cells, incubated for 48 h before 
UVA irradiation and ROS generation detection by flow cytometry. Data shown 
are mean ± SEM of three independent experiments. Values for ROS 
generation are expressed relative to untreated FEK4 cells. The student t test 
was used to evaluate the statistical significance of each data point.  
*p<0.05 when compared to untreated control cells.  
** p< 0.01 when compared with untreated FEK4 control cells 































Page | 127  
Apparently, although both siNOX1 RNA and siNOX4 RNA treatment had decreased 
the NOX1 and NOX4 protein expression level as described in the previous section, 
NOX1 or NOX4 gene knock down does not alter the UVA-mediated ROS generation 
after UVA irradiation in cultured human skin fibroblasts. These results are therefore 
in sharp contrast to the results seen in epidermal keratinocytes by Valencia and 
Kochevar (2008) who observed an almost 50% reduction in UVA-induced ROS using 
NOX1 siRNA treatment.  
In summary, although the siNOX1 and siNOX4 RNAs both reduced NOX activity in 
FEK4 cells as well as the protein expression level, this treatment does not inhibit UVA-
induced ROS generation. One possible explanation may be the confounding effect of 
scrambled siRNA, but there is also a possibility that the NOX1 and NOX4 proteins 
are both involved in the UVA-induced NOX activation, but that this is not sufficient to 
supress the UVA-induced ROS generation since the other NOX family proteins may 
be involved.  
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3.10 The effect of HO-1 knocking-down on NOX activity in cultured human skin 
keratinocytes after UVA irradiation. 
Finally, as mentioned in the introduction, there is evidence for the interaction 
of HO-1 with NOX. Therefore, based on the results obtained in this study, it is 
reasonable to propose that there will be interdependence between HO-1 and 
NOX following UVA irradiation. To further understand this, HO-1 was silenced 
using siHO-1 RNA treatment of HaCaT cells; NOX activity was measured after 
UVA irradiation, and the results (Figure 37) demonstrated that inhibiting HO-1 
decreased NOX activity after UVA irradiation.  
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Figure 37 The effect of silencing HO-1 on the activation of NOX activity by 
UVA irradiation of HaCaT cells. HaCaT cells were pre-treated with siHO-1 and 
incubated for 48 h before UVA irradiation. Cells were then lysed and the total 
protein was collected for the NOX activity assay. Values in the bar represent 
the NOX activity relative to unirradiated, untreated control. The value of 
untreated HaCaT cell was set to 1; other values were normalized to this value. 
All values are shown as mean ± SEM (n=3). The student t test was used to 
evaluate the statistical significance of each data point.  
*p<0.05 when compared to untreated control cells. 
p<0.05 when compared to UVA irradiated cells. 
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Lower NOX activity was observed in HO-1 depleted HaCaT cells that were 
subsequently treated with UVA irradiation (Figure 37). After 100 kJ/m2, the sisb 
RNA slightly decreased the NOX activity as compared with untreated cells, but 
a further reduction of NOX activity was observed with siHO-1 treatment 
compared with untreated cells. At a higher UVA dose, the sisb RNA decreased 
the NOX activity but the siHO-1 RNA treatment decreased further the activity 
compared to scrambled siRNA treatment.  
Induction of NOX1 gene expression by bilirubin was observed in 
lipopolysaccharide (LPS) activated cells (Weinberger et al., 2013). This 
provided evidence for the interaction between bilirubin and NOX1 gene 
activation. This finding could be a possible explanation for the results we have 
seen in this study i.e. the reduced NOX activity may be due to the lack of one 
of the HO-1 degradation products (bilirubin) in HO-1 depleted HaCaT cells. 
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Chapter 4 Discussions and conclusions 
HO-1 induction is well known to protect cells against UVA damage and Bach1 
is involved in the negative regulation of the HO-1 gene (Raval et al., 2012). 
Following on from these studies, we proposed that Bach1 inhibition would 
increase UVA-induced HO-1 and thereby enhance the protection of skin cells 
against UVA damage. FEK4 cells and HaCaT cells were chosen as the skin 
cell models in this study. However, the results from our experiments using 
Bach1 depletion in cultured FEK4 cells showed that there was no significant 
protection in Bach1 depleted skin fibroblasts compared with control cells. We 
then tested whether Bach1 inhibition could protect skin cells against UVA 
damage at the more sensitive ROS level, and we hypothesised that Bach1 
inhibition would reduce UVA-induced ROS damage. However, the results 
indicated that there is a rather higher ROS induction upon UVA treatment at 
higher UVA doses in Bach1 depleted cells. Based on the results of these 
Bach1 depletion experiments, we conclude that Bach1 inhibition has no 
protective role in the process of UVA-induced skin damage, at least for the 
parameters that we tested. This led us to consider in more depth the 
mechanism underlying ROS induction in UVA-irradiated skin cells. We  studied 
NADPH oxidase (NOX) for the rest of this study since it is considered as a 
major source of ROS generation and we hypothesised that it would be the 
major source of UVA-induced ROS generation. 
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4.1 Role of Bach1 in protecting against UVA-induced skin cell damage 
According to previous research (Raval et al., 2012; Raval., 2008), Bach1 
could act as a negative regulatory protein in the process of UVA-induced HO-
1 up-regulation. This study further investigated whether the inhibition of Bach1 
and the consequent increase in HO-1 would alter the UVA-mediated ROS 
response and skin cell damage. We hypothesized that inhibitory Bach1 would 
enhance HO-1 induction and thereby enhance protection against UVA 
damage in cultured human skin fibroblasts. Bach1 inhibition was achieved by 
silencing Bach1 using specific siRNA and the cell viability in response to UVA 
irradiation was examined to determine whether Bach1 inhibition would protect 
against cellular damage.  
However the results showed very little protection against cytotoxicity in Bach1 
depleted skin fibroblasts compared with control cells (as measured by the MTS 
assay). Although an oxygen-dependent lethal effect of UVA damage had been 
identified by colony forming ability assays in FEK4 fibroblasts, we considered 
it possible that the MTS assay did not pick up this effect. Thus, we performed 
glutathione depletion experiments and tested UVA dose-dependent reduction 
in MTS activity in control cells and the ones depleted of glutathione. This study 
provided evidence that the MTS assay is able to detect the UVA-induced 
oxidative damage effect. We therefore conclude that Bach1 inhibition effects 
on skin cells lead to no protective effect against UVA-induced cytotoxicity. We 
next questioned whether inhibiting Bach1 would lessen UVA-induced ROS 
generation and we investigated this further in human skin fibroblasts. 
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4.2 Bach1/HO-1 involvement in UVA-induced ROS generation  
To examine the effect of Bach1 inhibition on UVA-induced ROS generation, 
we examined UVA-induced ROS generation after inhibition of both Bach1 and 
HO-1. Consistent with the results described in the previous section, silencing 
Bach1 does not reduce UVA-induced ROS generation in skin fibroblasts; 
rather it increased ROS induction level at higher UVA dose. In addition to being 
involved in the oxidative stress response, Bach1 was recently found to be 
involved in cell cycle proliferation and apoptosis. The increase in ROS 
generation by Bach1 depletion may be due to other Bach1 mediated cellular 
events. Interestingly, silencing of HO-1 has little effect on UVA-induced ROS 
generation. Thus, although we have clearly inhibited Bach1 this is not sufficient 
to protect skin cells against UVA damage and has no effect on ROS generation. 
This also implies that the protective role of HO-1 induction after UVA treatment 
is independent of the UVA-induced ROS response.  
4.3 NOX involvement in UVA induced ROS generation 
Despite our prediction, it is evident that Bach1 inhibition does not protect skin 
cells against UVA induced damage. UVA generation of ROS appears to be a 
complex process that does not involve Bach1 or HO-1. This led us to 
investigate the role of NOX in UVA-induced ROS generation in cultured human 
skin cells. NOX activation occurrence has been proven in vitro under various 
stimuli; for example, treatment of angiotensin II in endothelial cells induces 
NOX activation (Cai et al., 2003). To examine whether NOX is involved in the 
process of UVA-induced ROS generation, we tested the response of NOX 
activity to UVA irradiation and the results demonstrated NOX activation occurs, 
although to different extents, in both FEK4 and HaCaT cells. It is interesting to 
note that NOX activation has been observed in human dermal fibroblasts 
following treatment with very long fatty acid (Dhaunsi et al., 2005).  
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We next investigated the effect of NOX inhibition on UVA-induced ROS 
generation. This study firstly showed that inhibiting NOX using the general 
NOX inhibitor DPI decreased ROS induction in human skin fibroblasts. A 
similar result was found in UVB irradiated human dermal fibroblasts (Lim et al., 
2013). A study in rat mast cells has shown that DPI abolished UVA-induced 
ROS generation (Zhou et al., 2009). 
In addition, ROS generation in skin fibroblasts was found to be cell confluency 
dependent. UVA radiation generates ROS to a higher extent in more confluent 
skin fibroblasts. We obtained evidence that the effect of DPI treatment on 
UVA-induced ROS generation is confluence dependent and that a low 
confluence level would increase ROS generation following UVA irradiation. 
Evidence from another laboratory has shown DPI treatment can induce ROS 
generation and consequently lead to cellular apoptosis in the human 
promyelocytic leukemia cell line, HL-60 (Li et al., 2003a). Studies in neurons 
in vitro found that NOX-derived ROS induction is involved in neuronal death 
under various conditions such as ketamine (Behrens et al., 2007) and stroke 
(i.e. reoxygenation) (Sorce and Krause, 2009). NOX inhibition by apocynin 
reversed these effects.  
4.4 The contribution of NOX1/NOX4 subunits  
In order to further understand which NOX subunit contributed to UVA-induced 
ROS generation, NOX1 and NOX4 were chosen in this study since they are 
the most widely studied and previous evidence has strongly indicated that they 
are involved in the ROS generating system.  
As mentioned in the introduction, it is evident that NOX4 activity was increased 
by docosahexaenoic acid (DHA) in human dermal fibroblasts and DHA-
induced ROS generation was abolished by both silencing NOX4 and chemical 
inhibition of NOX4 (i.e. plumbagin treatment) (Rossary et al., 2007). Similarly, 
in this study, we observed that basal levels of NOX activity were decreased to 
different extents with siNOX1 RNA and siNOX4 RNA treatment in both FEK4 
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and HaCaT cells. Following UVA irradiation, we tested protein expression 
levels in both FEK4 and HaCaT cells and the results showed that the 
expression of NOX1 and NOX4 proteins was up-regulated to different extents. 
This result indicated that these two NOX isoforms are both involved in the 
UVA-induced NOX activation process, although they contribute to different 
extents to protein expression levels and enzymatic activity levels. We also 
noted in this study that at basal level, overall NOX activity appears similar in 
between FEK4 cells and HaCaT cells. However the level of expression of 
NOX1 protein is higher in HaCaT cells than in FEK4 cells, whereas NOX4 
protein is expressed to a similar extent in both cell lines. This result implies 
that other NOX proteins in addition to NOX4 may account for the NOX activity 
in HaCaT cells. A recent study has shown that ROS generation via the NOX2 
activation pathway is involved in the wound healing process of HaCaT cells 
(Bui et al., 2014). 
There is evidence that silencing of either NOX1 or NOX4 isoforms can 
eliminate ROS induction by co-treatment with hapatocyte growth factor (HGF) 
and TGF-1 in HaCaT cells (Nam et al., 2010). In contrast with this result, 
NOX1 and NOX4 subunits were found to have only a limited contribution to 
UVA-induced ROS generation, suggesting the involvement of other NOX 
subunits in this process.  
In this study, the inhibitory effect of plumbagin was initially employed to inhibit 
NOX4 subunits, but the results revealed an unexpected role of plumbagin as 
a redox active molecule in addition to being a NOX4 inhibitor. We discovered 
that although plumbagin-treatment of skin cells alone strongly reduced UVA-
induced ROS generation levels, the compound alone strongly increased ROS 
generation in skin cells. We have detected cell death in skin cells (pre-treated 
with plumbagin) and the results confirmed increased apoptotic and necrosis. 
However, plumbagin completely abolished ROS generation by UVA irradiation. 
There is evidence that in human melanoma cells, plumbagin induces 
apoptosis via the generation of ROS (Wang et al., 2008). Powolny and Singh 
Page | 136  
(2008) also reported that plumbagin results in apoptosis through ROS 
generation in human prostate cancer cells. Thus, the decrease in ROS 
generation that we have observed may be due to the oxidising damage by 
plumbagin. In view of the confounding effects of such chemical inhibition, more 
specific gene knock down by siRNA targeting NOX1 and NOX4 was carried 
out as described in the previous section. 
In summary, this study has confirmed that NOX1 and NOX4 subunits both 
contribute to NOX total activity, and may influence on ROS generation 
following UVA irradiation in cultured human skin fibroblasts. However, 
additional subunits of NOX enzymes should also be employed for future study. 
Different NOX isoforms have been reported to be related to ROS-mediated 
events. NOX2-derived ROS was found to be involved in cell survival in the 
heart (Rosc-Schluter et al., 2012). NOX3-derived ROS may contribute to 
hearing loss (Banfi et al., 2004a). NOX5-derived ROS was found to be 
involved in the vasculature process in endothelial cells (BelAiba et al., 2007). 
A recent study has shown that in human normal keratinocytes, DUOX1-based 
ROS production was induced by IL-4 and IL-3 treatment (Hirakawa et al., 
2011). All these studies provided evidence that there are other NOX isoforms 
involved in the ROS mediated events. UVA-induced ROS generation may 
involve one or more NOX proteins other than NOX1 and NOX4. 
4.5 The relationship between HO-1 and NOX  
HO-1 induction has been shown to interact with NOX in different conditions; 
inhibition of NOX1 enzymatic activity has been shown to decrease HO-1 
expression in chronic myelogenous leukaemia cells (Singh et al., 2012). NOX 
has been shown to be involved in the upstream up-regulation of HO-1 
expression by arsenite in HaCaT cells (Cooper et al., 2009). Based on these 
findings, the relationship between HO-1 and NOX was also investigated in this 
study. We predicted that silencing of HO-1 would increase UVA-induced NOX 
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activity in HaCaT cells; the results however showed reduced NOX activity. 
Although silencing of HO-1 decreased UVA activation of NOX in skin 
keratinocytes in this study, the result clearly confirmed that HO-1 is involved 
in NOX activation upon UVA treatment. Although we expected that silencing 
of HO-1 would promote NOX activation, the results may emphasize the pro-
oxidant effect of HO-1, and one of the products of HO-1 degradation may also 
induce cellular damage. A previous study from our laboratory has 
demonstrated that HO-1 overexpression transitionally hyposensitized cells to 
UVA-induced cellular damage as a consequence of the release of iron (Kvam 
et al., 2000). This may be a reason why HO-1 inhibition decreases NOX 
activity following UVA treatment in skin keratinocytes, a mechanism which 
meant further study.  
Page | 138  
4.6 Conclusions 
In conclusion, this study has examined the role of Bach1 in UVA-induced HO-
1 induction as well as ROS generation in human skin cells. Our results 
revealed that Bach1 depletion is not sufficient to enhance the protective 
pathway mediated by UVA-induced HO-1. 
Furthermore, we tested the importance role of NOX in UVA-induced ROS 
generation. The results confirmed that UVA activates NOX in human skin cells 
and that inhibiting NOX activation decreases UVA-induced ROS. Nevertheless, 
targeting specific NOX subunits (NOX1/NOX4) did not modify ROS generation 
after UVA treatment.  
Future work should be done to investigate the effect of other NOX subunits. 
Although less is known about the role of NOX2/3/5 in human skin cells, 
published evidence that these subunits take part in ROS-mediated events 
encourages an investigation of the role of these NOX proteins in the process 
of UVA-induced ROS generation in human skin cells. The contribution of 
NOX1 and NOX4 to UVA-induced ROS generation in HaCaT cells was not 
performed further in this study due to technical difficulties and merits further 
study. Little is known about the function of DUOX1/2, but evidence that 
DUOX1 contributes the ROS production in HaCaT cells under certain stimuli 
supports the investigation of DUOX1 as a possible candidate for UVA-induced 
ROS generation in HaCaT cells. Our study shown that NOX-derived ROS are 
a major source of UVA-induced ROS generation in cultured human skin cells 
and therefore that inhibiting the activate sites of the appropriate subunits 
provide a potential target for prevention of UVA-induced skin damage. 
Since HO-1 is found to interact with NOX activity in the process of UVA 
activated NOX, the relationship between HO-1 and NOX also merits further 
investigation as one of the potential protective pathways against UVA-induced 
cellular damage. For example, it would be of value to investigate whether NOX 
activation is upstream of UVA-induced HO-1 induction and this would be of 
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value in understanding the mechanism of antioxidant properties of UVA-
induced HO-1. This can be studied as a potential antioxidant mechanism 
pathway of UVA-induced HO-1 in cultured human skin cells in the future. 
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Appendix  
Appendix 1  Flow cytometry data presenting of ROS generation in live 
cultured human skin cells. Red coloured area represents for the value of the 
ROS dye (CM-H2DCFDA) labelled fluoresce intensity which was proportional 
to the ROS generation. Values were generated by the fluorescence intensity 
that measured by flow cytometer in the living single cell. The peak (i.e. 
representing the median value of fluorescence intensity) shifting (black arrow) 
indicates the UVA induced ROS generation in comparison with control (ctrl). 
